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A high-content RNAi screen reveals multiple roles
for long noncoding RNAs in cell division
Lovorka Stojic 1,6✉, Aaron T. L. Lun 1,7,13, Patrice Mascalchi1,8,13, Christina Ernst1,9,
Aisling M. Redmond 1,10, Jasmin Mangei1,11, Alexis R. Barr 2,12, Vicky Bousgouni2, Chris Bakal 2,
John C. Marioni1,3,4, Duncan T. Odom 1,5✉ & Fanni Gergely 1✉
Genome stability relies on proper coordination of mitosis and cytokinesis, where dynamic
microtubules capture and faithfully segregate chromosomes into daughter cells. With a high-
content RNAi imaging screen targeting more than 2,000 human lncRNAs, we identify
numerous lncRNAs involved in key steps of cell division such as chromosome segregation,
mitotic duration and cytokinesis. Here, we provide evidence that the chromatin-associated
lncRNA, linc00899, leads to robust mitotic delay upon its depletion in multiple cell types. We
perform transcriptome analysis of linc00899-depleted cells and identify the neuronal
microtubule-binding protein, TPPP/p25, as a target of linc00899. We further show that
linc00899 binds TPPP/p25 and suppresses its transcription. In cells depleted of linc00899,
upregulation of TPPP/p25 alters microtubule dynamics and delays mitosis. Overall, our
comprehensive screen uncovers several lncRNAs involved in genome stability and reveals a
lncRNA that controls microtubule behaviour with functional implications beyond cell division.
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Long noncoding RNAs (lncRNAs) are defined as RNAslonger than 200 nucleotides that lack functional openreading frames, and represent a major transcriptional output
of the mammalian genome1,2. LncRNAs control numerous cel-
lular processes including the cell cycle, differentiation, prolifera-
tion and apoptosis3–5 and their deregulation is associated with
human disease including cancer6,7. Several lncRNAs regulate the
levels of key cell cycle regulators such as cyclins, cyclin-dependent
kinases (CDK), CDK inhibitors and p538,9. LncRNAs are also
linked to cell division as they can regulate the levels of mitotic
proteins10,11 or by modulating the activity of enzymes involved in
DNA replication and cohesion12. In addition, lncRNAs can
control chromosome segregation by controlling kinetochore for-
mation via centromeric transcription13 or by acting as decoys for
RNA-binding proteins involved in maintaining genome stabi-
lity14,15. All of these lncRNA-dependent functions can occur
through transcriptional and posttranscriptional gene regulation,
chromatin organisation and/or posttranslational regulation of
protein activity5. These mechanisms usually involve lncRNAs
establishing interactions with proteins and/or nucleic acids, which
allows lncRNA-containing complexes to be recruited to specific
RNA or DNA targets16. Although lncRNAs represent >25% of all
human genes (GENCODE v24), the biological significance of the
majority of lncRNAs remains unknown.
Systematic screens in human cells identify protein-coding
genes involved in cell survival, cell cycle progression and chro-
mosome segregation17–20. Similar loss-of function screens are
performed to identify lncRNAs with cell cycle functions. For
example, CRISPR interference (CRISPRi) is used in high-
throughput screens to identify lncRNA loci important for cell
survival21 and revealed lncRNAs whose functions were highly
cell-type specific. Similar results are obtained in a CRISPR/
Cas9 screen targeting lncRNA splice sites22. In a recent RNA
interference (RNAi) screen targeting human cancer-relevant
lncRNAs, Nötzold and colleagues used time-lapse microscopy
imaging of HeLa Kyoto cells and identify 26 lncRNAs linked to
cell cycle regulation and cell morphology23. However, this screen
only studied ~600 lncRNAs in the genome with respect to a
limited number of phenotypes.
With an aim to identify lncRNAs with functions in cell divi-
sion, we perform a more comprehensive high-content imaging
RNAi screen involving the depletion of 2231 lncRNAs in HeLa
cells. We develop image analysis pipelines to quantify a diverse set
of mitotic features in fixed cells, and discover multiple lncRNAs
with roles in mitotic progression, chromosome segregation, and
cytokinesis. We focus on linc00899, a hitherto uncharacterised
lncRNA that regulates mitotic progression by repressing the
transcription of the microtubule-stabilising protein TPPP/p25.
Our study demonstrates the regulatory function of linc00899 in
mitotic microtubule behaviour and provides a comprehensive
imaging data resource for further investigation of the roles of
lncRNAs in cell division.
Results
High-content RNAi screen identifies lncRNAs in cell division.
To identify lncRNAs involved in regulating cell division, we per-
formed two consecutive RNAi screens (screen A and B). Briefly,
we transfected HeLa cells with the human Lincode small inter-
fering RNA (siRNA) library targeting 2231 lncRNAs (Fig. 1a;
Supplementary Data 1) and examined their effects using high-
content screening of mitotic phenotypes. Each lncRNA was tar-
geted with a SMARTpool of four different siRNAs. Following 48-h
incubation, cells were fixed and processed for immunostaining
and subsequent automated image acquisition and analysis.
In screen A, antibodies targeting CEP215 (to label centrosomes),
α-tubulin (to label the microtubule cytoskeleton), phalloidin (to
label the actin cytoskeleton) and Hoechst (to label nuclei) were
used. In screen B (Fig. 1b–d), phospho-histone H3 (PHH3; to
specifically label mitotic cells), α-tubulin, γ-tubulin (to label cen-
trosomes) and Hoechst was used. We used these two screens
as independent approaches to robustly identify lncRNAs with
functions in mitotic progression, chromosome segregation and
cytokinesis.
In each screen, we employed automated image analysis to
segment the cells and developed in-house pipelines to quantify
defects in each of abovementioned categories upon lncRNA
depletion (Supplementary Fig. 1a). First, for defects in mitotic
progression, we determined the percentage of mitotic cells
(also called mitotic index), because an increase in the mitotic
index implies a delay or block in mitotic progression. We
performed nuclear segmentation and computed the mitotic
index (Supplementary Fig. 1b) where mitotic cells were identi-
fied by the presence of mitotic spindle staining (detected
by α-tubulin and CEP215) in screen A or by positive PHH3
staining of chromosomes in screen B. Second, for quantification
of chromosome segregation defects, a category that includes
chromatin bridges and lagging chromatids, we identified anaphase
cells based on α-tubulin staining between the separating nuclei, in
addition to Hoechst (DNA) signal (Supplementary Fig. 1c). Third,
to evaluate defects in the execution of cytokinesis, we segmented
the cytoplasm of interphase cells and scored the number of cells
with cytokinetic bridges based on α-tubulin staining (Supplemen-
tary Fig. 1d).
For each category, we ascertained lncRNAs for which depletion
increased the frequency of defects relative to the mean across
all lncRNAs in the siRNA library. Negative control siRNA and
cells without any siRNA treatment were used as controls, for
which we observed no systematic differences in the frequencies of
each phenotype (Fig. 1b–d). We identified candidate lncRNAs
involved in mitotic progression (Fig. 1a; linc00899 and C1QTNF1-
AS1), chromosome segregation (Fig. 1b; PP7080 and linc00883)
and cytokinesis (Fig. 1c; linc00840 and loc729970). As a positive
control for mitotic progression defects, we used a SMARTpool
against the protein-coding gene Ch-TOG/CKAP5, whose deple-
tion leads to mitotic delay and increased mitotic index24 (Fig. 1b).
For chromosome segregation, we successfully identified the
lncRNA NORAD (Fig. 1c), depletion of which increases the rate
of chromosome segregation errors14,15. Supplementary Data 2
contains raw data and computed Z-scores for each lncRNA and
phenotype.
To confirm our findings, we conducted a validation screen
targeting the top 25 lncRNA candidates identified in the initial
screens for mitotic progression and cytokinesis (Supplementary
Data 3). Depletion of each lncRNA was performed in two
biological (and in total eight technical) replicates. For mitotic
progression, this screen corroborated the increase in mitotic index
following depletion of linc00899 and C1QTNF1-AS1 (Supplemen-
tary Fig. 2a). Although loc100289019-depleted cells also displayed
an elevated mitotic index, levels of the lncRNA did not change
upon RNAi25. For the cytokinesis category, we observed an
increase in the number of cells with cytokinetic bridges after
linc00840 depletion and a decrease after loc729970 depletion, but
neither led to multinucleation (Supplementary Fig. 2b, c).
Furthermore, elevated mitotic index and cytokinesis defects were
not associated with reduced cell viability for these lncRNAs
(Supplementary Fig. 2d). As positive controls, we used Ch-TOG
and ECT2 (a key regulator of cytokinesis)26, the depletion of
which led to expected phenotypes: an increased number of mitotic
and multinucleated cells, respectively (Supplementary Fig. 2a–c).
Mitotic perturbations caused by depletion of the lncRNA
candidates were further characterised by time-lapse microscopy
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imaging to investigate the dynamics of each phenotype. As
expected, a marked mitotic delay was observed in HeLa cells
depleted of linc00899 and C1QTNF1-AS1, lncRNAs associated
with increased mitotic index (Supplementary Fig. 3). Next, we
depleted linc00883 and PP7080, lncRNAs with potential functions
in chromosome segregation (Supplementary Fig. 4). Using time-
lapse microscopy imaging of HeLa Kyoto cells stably expressing
histone H2B-mCherry (a chromatin marker) and eGFP-α-tubulin
(a microtubule marker)18, we found that depletion of linc00883
and PP7080 increased the rate of chromosome segregation errors
to a similar extent as that of NORAD. We then depleted linc00840
and loc729970 (Supplementary Fig. 5), lncRNAs from the
cytokinesis category, and found that knockdown of linc00840
doubled the time required for cells to cleave the cytokinetic
bridge, whereas knockdown of loc729970 resulted in shorter
cytokinesis. Overall, our screen identified functions of lncRNAs in
the control of cell division, supporting the idea that lncRNAs play
an important role in cell cycle progression.
Molecular characterisation of linc00899 and C1QTNF1-AS1.
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linc00899 and C1QTNF1-AS1, were selected for in-depth func-
tional analysis. Linc00899 and C1QTNF1-AS1 are spliced and
polyadenylated lncRNAs. Linc00899 (also known as loc100271722
or ENSG00000231711) is a multi-exonic intergenic lncRNA
located on chromosome 22 and is ~1.6 kb long. C1QTNF1-AS1
(also known as ENSG00000265096) is an lncRNA on chromo-
some 17 that is ~1 kb long and is antisense to a protein-coding
gene “C1q And TNF Related 1” (C1QTNF1/CTRP1). Both
lncRNAs are annotated in GENCODE, show signs of active
transcription (Fig. 2a) and have low protein-coding potential
(Supplementary Fig. 6a). Although we did not identify a syntenic
ortholog for linc00899 in the mouse genome, short stretches of
conserved regions27 are present within exon 1 (Supplementary
Fig. 6b). This places linc00899 in a group of lncRNAs with con-
served exonic sequences embedded in a rapidly evolving tran-
script architecture28. Based on the syntenic position of protein-
coding gene C1QTNF1, we found a mouse ortholog for
C1QTNF1-AS1 (GM11747, ENSMUG000000086514) that is also
antisense to the mouse C1qtnf1. Thus C1QTNF1-AS1 is an
lncRNA that is conserved across mouse and human, while
linc00899 contains short conserved stretches at its 5′ end repre-
senting possible functional domains29,30.
We then validated the expression of both lncRNAs in HeLa cells
using a variety of techniques. cDNA generated from polyadeny-
lated RNA was used for rapid amplification of cDNA ends (RACE)
to define the locations of the 5′ cap and 3′ end identifying several
isoforms for linc00899 and C1QTNF1-AS1 (Supplementary Fig. 6c).
The diversity of isoforms for both lncRNAs is consistent with a
previous study on lncRNA annotation27. Expression data from
ENCODE cell lines indicated that linc00899 and C1QTNF1-AS1
were present in both the nucleus and cytoplasm of HeLa-S3 cells
(Fig. 2b), which we further confirmed by RNA fluorescence in situ
hybridisation (RNA FISH) (Fig. 2c). Quantitative real-time
polymerase chain reaction (qPCR) analyses on RNA extracted
from different cellular fractions revealed that linc00899 but not
C1QTNF1-AS1 is associated with chromatin (Fig. 2d). Although
some linc00899 foci remain detectable in mitotic cells (Supple-
mentary Fig. 6d), they do not associate with mitotic chromatin,
arguing against a mitotic bookmarking role for these lncRNAs.
linc00899 and C1QTNF1-AS1 are estimated to occur, on average,
in five and two copies per cell, respectively, and do not show cell
cycle dependency in their expression (Supplementary Fig. 6e, f). In
the Genotype-Tissue Expression (GTEx) RNA-seq dataset31 from
human tissue, C1QTNF1-AS1 was highly expressed in the adrenal
gland and spleen, while linc00899 was broadly expressed in most of
the tissues, with uterus being the highest (Supplementary Fig. 6g).
Linc0889 and C1QTNF1-AS1 facilitate timely mitotic progres-
sion. To characterise the mitotic phenotype further, we depleted
linc00899 and C1QTNF1-AS1 in HeLa and HeLa Kyoto cells and
examined the effect on mitotic progression with immuno-
fluorescence and time-lapse microscopy imaging, respectively.
Quantification of lncRNA-depleted cells using RNAi revealed an
increase in the mitotic index compared to cells treated with
control siRNA (Fig. 3a, b). This was confirmed by time-lapse
microscopy imaging of HeLa Kyoto cells where depletion of
linc00899 and C1QTNF1-AS1 resulted in increased mitotic
duration (Supplementary Fig. 7a–c). We found that cells treated
with control siRNA initiated anaphase onset at 40 ± 10 min
(median ± SD), whereas the cells depleted of linc00899 and
C1QTNF1-AS1 initiate anaphase onset at 100 ± 173 and 240 ±
146 min, respectively (Fig. 3c). Although unaligned chromosomes
near spindle poles were detectable in a small population of
linc00899-depleted cells (and these showed delays of >4 h), in the
majority of cells bipolar spindle formation and chromosome
congression occurred with normal kinetics, and cells exhibited a
delay in the metaphase to anaphase transition (Fig. 3d upper
panels and Supplementary Movies 1 and 2). By contrast, nearly all
C1QTNF1-AS1-depleted cells showed an impairment of chro-
mosome congression to the metaphase plate (Fig. 3d lower panels
and Supplementary Movie 3).
We next asked whether these phenotypes could be recapitu-
lated by a loss-of-function (LOF) method other than RNAi. We
used locked nucleic acid (LNA) oligonucleotides as a comple-
mentary method to target lncRNA expression due to their higher
efficiency in depleting nuclear compared to cytoplasmic
lncRNAs32,33. We successfully depleted both linc00899 and
C1QTNF1-AS1 with two different LNAs and selected the LNA
with more efficient depletion (denoted LNA1) for subsequent
studies (Fig. 3e). Similar to RNAi, we observed an increase in the
mitotic index following LNA1-mediated depletion of linc00899
and C1QTNF1-AS1 (Fig. 3f) and confirmed the mitotic delay with
time-lapse microscopy imaging of HeLa Kyoto cells (Fig. 3g, h;
Supplementary Fig. 7d–f and Supplementary Movies 4–6).
The apparent increase in α-tubulin intensity at the spindle
poles of C1QTNF1-AS1-depleted cells is most likely due to
spindles being short and multipolar. Together, these data indicate
that linc00899 and C1QTNF1-AS1 have biological functions
in regulation of mitotic progression, albeit through different
mechanisms.
To further confirm the phenotype of C1QTNF1-AS1 depletion,
we inserted a polyadenylation poly(A) signal (pAS)34 downstream
of the C1QTNF1-AS1 transcriptional start site (TSS) using CRISPR-
Cas9 gene editing. This method allows lncRNAs to be transcribed
but terminates them prematurely due to the inserted pAS,
preventing the expression of full-length lncRNA transcripts. We
obtained four homozygous clones for C1QTNF1-AS1 with similar
knockdown efficiency, all of which displayed mitotic delay similar to
Fig. 1 Identification of lncRNAs involved in regulation of cell division. a Schematic representation of the high-throughput RNAi imaging screen for
lncRNAs regulating three mitotic processes: mitotic progression, chromosome segregation and cytokinesis. The screen depleted each of 2231 lncRNAs in
HeLa cells using the Human Lincode siRNA library (Dharmacon). b Z-scores for mitotic progression defects upon depletion of each lncRNA in the siRNA
library. Each point corresponds to a single lncRNA where the Z-score was computed based on the mean mitotic index (MI). siRNAs against the protein-
coding gene Ch-TOG were used as positive controls, in addition to negative control siRNAs (Ctl, from Ambion). Representative images from the top
candidate (linc00899, in blue) are also shown, with PHH3 in yellow indicating mitotic cells (white circles). c Z-scores for chromosome segregation defects
upon lncRNA depletion, similar to b. The Z-score per lncRNA was computed from the mean number of chromosome segregation errors (CSE). Here
NORAD (grey) was used as a positive control. Top candidates are highlighted in purple. Representative images from one of the top candidates (linc00883,
in purple) are also shown with staining for α-tubulin (red), PHH3 (green) and γ-tubulin (yellow). Inset depicts normal anaphase cell (blue area) or
anaphase cell with CSE (yellow area). d Z-scores for cytokinesis defects upon lncRNA depletion, similar to a. The Z-score for each lncRNA was computed
based on the mean number of cells with cytokinetic bridges (CB). Representative images from the top candidate (linc00840, in orange) are shown with
staining for α-tubulin (red) and DNA (blue). CB are depicted in white circles. All Z-scores shown here are from screen B. Some of the top candidates are
shown in colour and labelled in each plot. The scale bar for all images is 20 μm. Tables below each panel represent the raw data and calculated Z-scores for
top lncRNA candidates for each category from two independent screens (A and B).
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RNAi- and LNA-mediated depletion of C1QTNF1-AS1 (Supple-
mentary Fig. 8). These results suggest that the C1QTNF1-AS1
transcript, and not transcription at the C1QTNF1-AS1 locus, is
required for the regulation of mitotic progression. Similar experi-
ments for linc00899 were hindered by the presence of over four
copies of linc00899 in the HeLa genome (https://cansar.icr.ac.uk/
cansar/cell-lines/HELA/copy_number_variation/) preventing the
generation of homozygous clones despite the use of two different
guide RNAs (gRNAs) targeting different regions of linc00899.
Linc0889-dependent regulation of TPPP in mitotic progression.
To reveal transcriptional regulatory functions of linc00899 and
C1QTNF1-AS1, we performed RNA sequencing (RNA-seq) of
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cells following RNAi- and LNA-mediated depletion of
each lncRNA. We selected the subset of differentially
expressed genes (DEGs) that changed in a consistent direction
with both LOF methods to minimise any potential method
specific off-target effects as shown previously25. For C1QTNF1-
AS1, a single DEG was detected, which was C1QTNF1-AS1
itself (Fig. 4a). These data argue against a transcriptional
role for C1QTNF1-AS1 and suggest that its function in
mitotic progression could depend on C1QTNF1-AS1 protein
interactors.
For linc00899, we identified eight DEGs in common across the
two LOF methods (Fig. 4a), of which four were changing in the
same direction with both methods (Fig. 4b). Since we were not
able to validate changes in RAI14, DNAAF5 and ITGB1BP1
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expression at the mRNA and protein levels (Supplementary
Fig. 9), we decided to focus on TPPP/p25.
TPPP/p25 is a tubulin polymerisation-promoting protein with
established roles in microtubule dynamics and mitosis35,36. TPPP
was upregulated upon RNAi- and LNA-mediated depletion of
linc00899 (Fig. 4c, d), which we validated at the protein level in
asynchronous (Fig. 4e, f) as well as in mitotic cells (Supplemen-
tary Fig. 10a).
To address whether the mitotic delay in linc00899-depleted
cells is due to increased TPPP levels, we performed single and
double knockdowns of linc00899 and TPPP and analysed the
mitotic progression (Fig. 4g). Whereas TPPP knockdown alone
did not affect mitotic timing, depletion of linc00899 alone in HeLa
cells led to a mitotic delay, consistent with results from HeLa
Kyoto cells (Fig. 3c, g). However, cells with simultaneous
depletion of linc00899 and TPPP progressed through mitosis
with near-normal timing, a phenotype observed with both LOF
methods. We confirmed that co-depletion of linc00899 and TPPP
rescued the previously observed upregulation of the latter with
qPCR (Fig. 4h, i). Similar results were obtained with an additional
LNA oligonucleotide targeting the first intron of linc00899
(Supplementary Fig. 10b, c). These data suggest that linc00899
needs to be depleted at least by 50% to attain TPPP upregulation
and mitotic delay in HeLa cells (Supplementary Fig. 10d, e).
Linc00889 controls microtubule dynamics in the spindle. TPPP
is known to localise to the mitotic spindle, and its overexpression
influences microtubule dynamics and stability in mammalian
cells35–38. Overexpression of TPPP increases tubulin acetylation
and also microtubule stability via microtubule bundling36. Thus
we tested whether depletion of linc00899, which leads to upre-
gulation of TPPP, had a similar effect. Immunofluorescence of
linc00899-depleted cells using antibodies against α-tubulin
(a microtubule marker) and acetylated α-tubulin (a marker of
long-lived microtubules)39 showed a marked increase in acety-
lated α-tubulin levels (Fig. 5a), consistent with linc00899-depleted
cells containing more long-lived microtubules. We next bench-
marked the effects of linc00899 depletion on microtubules to
those exerted by paclitaxel (taxol), a microtubule-stabilising agent
that suppresses microtubule dynamics at nanomolar doses40,41.
Cells were treated with 0.5–3 nM taxol, concentrations that sup-
press microtubule dynamics without affecting spindle morphol-
ogy42 because high doses of taxol (5 nM–1 µM) block microtubule
depolymerisation leading to highly aberrant mitotic spindles and
cell death40. We analysed cells after 1- or 20-h taxol treatment.
We found that the impact of linc008999 depletion on acetylated
α-tubulin levels was comparable to that of 3 nM taxol (Fig. 5b, c),
suggestive of impaired microtubule dynamics in linc008999-
depleted cells.
As TPPP influences the growth velocity of microtubules by
affecting their stability36, we examined the localisation of EB1
protein, which specifically associates with growing microtubule
plus-ends where it regulates microtubule dynamics43. As
expected, EB1 staining was apparent at the spindle pole and
throughout the spindle in control cells but it was much reduced in
intensity upon linc00899 depletion (Fig. 5d). Importantly,
reduced EB1 signal was not due to diminished microtubule
levels, because α-tubulin staining of the mitotic spindle was
comparable between linc00899-depleted and control cells. Quan-
tification of EB1 signal in mitotic cells confirmed the decrease in
EB1 levels, indicating that linc00899 depletion lessens the number
of growing microtubule ends, a phenotype consistent with a
reduction in microtubule dynamics (Fig. 5e). Taken together,
these data demonstrate that, by controlling TPPP expression
levels, linc00899 limits the number of long-lived microtubules and
maintains normal microtubule dynamics in mitotic HeLa cells.
To gain insight into why depletion of linc00899 and C1QTNF1-
AS1 causes a mitotic delay, we examined the distribution of the
kinetochore (CREST) and spindle (α-tubulin) markers in HeLa
cells depleted of these lncRNAs (Fig. 6a). In contrast to controls,
where most chromosomes were present in a narrow or wide
metaphase plate, ~20% of linc00899-depleted mitotic cells
displayed narrow metaphase plates with single unattached
kinetochore pairs near the poles (congression defect I; Fig. 6a
and Supplementary Fig. 11). Congression defects appeared even
more severe in C1QTNF1-AS1-depleted cells, which showed very
wide metaphase plates with several clusters of chromosomes
surrounding both spindle poles (congression defect II; Fig. 6a and
Supplementary Fig. 11). Phenotypes were confirmed with LNA-
mediated depletion for both lncRNAs. The differences in mitotic
phenotypes suggest that the mechanisms through which these
two lncRNAs control mitotic progression are likely to be
different.
Spindle assembly checkpoint (SAC) signalling at the kinetochores
ensures that each and every chromosome is bi-oriented on the
metaphase plate before anaphase is initiated44. To assess the status
of SAC, we immunostained control and linc00899-depleted cells for
the presence of Mad2, an essential component of the SAC signalling
machinery45,46 (Fig. 6b). Frequency of Mad2 on narrow metaphase
plates appeared slightly reduced in linc00899-depleted cells when
compared to controls (12% vs 20%). However, this may not be of
biological significance because 89% of linc00899-depleted cells with
narrow metaphase plates exhibited Mad2 signal on the sister
kinetochores of these uncongressed chromosomes. Thus active SAC
Fig. 3 Linc00899 and C1QTNF1-AS1 regulate mitosis through different mechanisms. a Expression of linc00899 and C1QTNF1-AS1 after RNAi depletion, as
measured by qPCR. Results are also shown for negative control siRNAs (Ctl, from Ambion) and for cells treated with transfection reagent only (Cells). n=
3 (C1QTNF1-AS1) and 6 (linc00899) biological replicates, ****P < 0.0001 by two-tailed Student’s t test. Expression values are presented relative to control
siRNA. b Changes in the mitotic index (MI, based on PHH3 and Hoechst staining) after RNAi-mediated depletion of linc00899 and C1QTNF1-AS1
determined 48 h after siRNA transfection. n= 4 biological replicates, *P < 0.05 by Mann–Whitney test. c Quantification of mitotic duration from time-lapse
microscopy imaging after depletion of linc00899 and C1QTNF1-AS1 in HeLa Kyoto cells. We analysed n= 183 for cells treated with Ctl si, n= 241 for Cells,
n= 163 for linc00899 siRNAs and n= 147 for C1QTNF1-AS1 siRNAs. Bars show the median and the interquartile range from three biological replicates.
****P < 0.0001 by Mann–Whitney test. d Representative still images from time-lapse microscopy from c. Scale bar, 5 µm. e Expression of linc00899 and
C1QTNF1-AS1 after depletion using two different LNA gapmers, as measured by qPCR. Results are also shown for negative control LNAs (Ctl LNA A and B)
and for Cells. n= 3 biological replicates, ***P < 0.001 and ****P < 0.0001 by two-tailed Student’s t test. Expression levels are presented relative to Ctl LNA
A. f Changes in the MI after depletion of linc00899 and C1QTNF1-AS1 using LNA1 gapmers, as measured in b. n= 4 biological replicates, *P < 0.05 by
Mann–Whitney test. g Quantification of mitotic duration as in c after depleting linc00899 and C1QTNF1-AS1 with LNA1 gapmers. We analysed n= 273 for
Ctl LNA A, n= 312 for Cells, n= 138 for linc00899 LNA1 and n= 349 for C1QTNF1-AS1 LNA1. Bars show the median and interquartile range from three
biological replicates. ****P < 0.0001 by Mann–Whitney test. h Representative still images from time-lapse microscopy from g. Scale bar, 5 µm. Data are
shown as mean ± S.E.M for a, b, e, f. Mitotic duration in c, g was defined from NEBD (t= 0min) to anaphase onset. Source data are provided as a Source
Data file.
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due to uncongressed chromosomes contributes to the mitotic delay
in linc00899-depleted cells.
Once chromosome bi-orient, they come under tension from
pulling forces generated by kinetochore microtubules. Given the
central role of microtubule dynamics in this process, and its
impairment in linc00899-depleted cells, we determined the
interkinetochore distances (inter-KT) of chromosomes, which
are known to report of the tension that kinetochore pairs are
subjected to (Fig. 6c, d)47. Whereas in cells treated with negative
control siRNA or control LNA, the mean inter-KT distance was
1.4 ± 0.2 µm, bi-oriented chromosomes in linc00899-depleted
cells had a reduced mean inter-KT distance of 1.2 ± 0.2 µm
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Fig. 4 TPPP, a microtubule-stabilising protein, is a target of linc00899 in regulation of mitosis. a Venn diagram of DEGs detected by RNA-seq after
depletion of linc00899 and C1QTNF1-AS1 using RNAi and LNA1 gapmers. The total number of genes was 17022. b Heat map of DEGs detected with RNA-
seq after depletion of linc00899 using RNAi and LNA gapmers. Three to four biological replicates were generated for each condition and compared to
appropriate negative controls (Ctl)—A and B for LNA gapmers, Ambion (Amb) and Dharmacon (Dh) for RNAi. Only DEGs changing in the same direction
with both LOF methods are shown. Linc00899 itself is shown as a reference. c Genome tracks of RNA-seq coverage for linc00899 before and after depletion
of linc00899 using RNAi or LNA1 gapmers. The tracks were constructed from averages of 3–4 biological replicates for each condition. d Genome tracks of
RNA-seq coverage for TPPP, as in c. e Representative western blot of TPPP levels after depletion of linc00899. β-Tubulin and p150 were used as two loading
controls. f Densitometric analysis of TPPP levels in e. n= 6 biological replicates. **P < 0.01 and ***P < 0.001 by two-tailed Student’s t test. g Quantification
of mitotic duration of HeLa cells after single and double knockdown of linc00899 and TPPP using RNAi or LNAs. We analysed n= 153 for cells treated with
transfection reagent alone (Cells), n= 187 for negative control siRNA (Ctl, from Ambion), n= 207 for TPPP siRNAs, n= 97 for linc00899 siRNAs, n= 204
for linc00899 and TPPP siRNAs, n= 182 for Ctl LNA A, n= 115 for linc00899 LNA1 and n= 246 for linc00899 LNA1 and TPPP siRNA. For each condition,
we show the median with interquartile range from two biological replicates. ****P < 0.0001 by Mann–Whitney test. Mitotic duration was defined from
NEBD (t= 0min) to anaphase onset. h–i Expression of linc00899 and TPPP after single or double knockdown with RNAi (h) or LNA1 gapmers (i) to
deplete linc000899. n= 4 biological replicates, *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001 by two-tailed Student’s t test. Data are shown as
mean ± S.E.M. for f, h, i. Source data are provided as a Source Data file.
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(1 h) based on immunofluorescence as in a. Scale bar, 5 µm for a, b. c Quantification of acetylated α-tubulin intensity over the total level of α-tubulin from
maximum intensity projections obtained in a, b. Numbers of cells analysed is n= 49 for cells treated with 0.05% DMSO (1 h), n= 30 for cells treated with
0.5 nM taxol (1 h), n= 45 for cells treated with 3 nM taxol (1 h), n= 29 for cells treated with Ctl si and n= 33 for linc00899 RNAi. We also quantified
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*P < 0.05, ***P < 0.001 and ****P < 0.0001 by Mann–Whitney test. d EB1 signal in HeLa cells after RNAi-mediated linc00899 depletion or treatment with Ctl
si based on immunofluorescence after staining with antibodies against α-tubulin (in red) and EB1 (in green). Images correspond to maximum intensity
projections of confocal micrographs. DNA is shown in blue. Scale bar, 10 µm. e Quantification of EB1 intensity from maximum intensity projections obtained
in d. Numbers of cells analysed is n= 39 for Ctl si and n= 38 for linc00899 RNAi. Swarm plots represent values from single mitotic cells, with the median
represented by the horizontal line. ****P < 0.0001 by Mann–Whitney test. Source data are provided as a Source Data file.
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Student’s t test. Scale bar, 5 µm. b Mad2 is present on kinetochores of unaligned chromosomes in linc00899-depleted mitotic cells. Representative images
of metaphase cells after RNAi-mediated depletion of linc00899. Cells were stained for Mad2 (SAC protein, in green) and with CREST (red). In cells treated
with negative control siRNA (Ctl), Mad2-positive kinetochores were detectable in 20% of cells with narrow metaphase plates, whereas this figure was 12%
in linc00899-depleted cells. In all, 89% of linc00899-depleted cells with congression defects were positive for Mad2. DNA was stained with Hoechst and is
shown in blue in the merged images. Scale bar, 5 µm. c Representative images representing maximum intensity projections of interkinetochore (inter-KT)
distance in HeLa cells after RNAi- and LNA-mediated depletion of linc00899. Cells were stained with CREST (red) and Hoechst (blue). Scale bar, 5 µm.
d Insets show examples for individual KT pairs from single focal planes based on CREST staining. Scale bar, 0.5 µm. e Quantification of inter-KT distance in
cells after linc00899 depletion as in c. A total of 152, 270, 121, 140 and 50 kinetochore pairs (from left to right; at least 7 pairs per cell) were measured for
each condition. Numbers of metaphase cells analysed is n= 18 for Ctl si, n= 26 for linc00899 RNAi, n= 14 for Ctl LNA A, n= 13 for linc00899 LNA1, and
n= 15 for cells with uncongressed chromosomes from linc00899-depleted cells. For each condition, we show the median with interquartile range. ****P <
0.0001 one-way ANOVA test. Source data are provided as a Source Data file.
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(Fig. 6e). Thus depletion of linc00899 leads to an overall decrease
in tension across sister kinetochores.
In summary, we have demonstrated that linc00899 depletion
suppresses microtubule dynamics, causes a chromosome con-
gression defect and reduces tension on the metaphase plate. These
defects are expected to preclude timely inactivation of the SAC,
thus delaying anaphase onset.
Linc00899 regulates TPPP and mitosis in multiple cell lines.
We next asked whether linc00899-mediated regulation of TPPP
occurs in cell lines other than HeLa. RNAi-mediated depletion of
linc00899 resulted in upregulation of TPPP in three normal
diploid cell lines (hTERT-RPE1, retinal pigment epithelial cells;
MCF10A, untransformed breast epithelial cells; HUVEC, primary
human umbilical vein endothelial cells) where mitosis is ~25 min
(Fig. 7a, c, e). Elevated TPPP levels were accompanied with a
mitotic delay from ~8 to 16 min upon linc00899 knockdown
(Fig. 7b, d, f). This delay was smaller compared to a mitotic delay
in HeLa cells and is most likely due to the presence of at least 82
chromosomes in HeLa cells that need to be aligned at the
metaphase plate, compared to 46 chromosomes present in normal
diploid cells. Indeed, the mitotic timing in HeLa cells is at least
~15 min longer than in RPE1, MCF10A and HUVEC cells. Thus
linc00899 regulates mitotic progression by controlling TPPP levels
in multiple cell lines.
In addition to its mitotic functions, TPPP is crucial for
microtubule organisation in the brain. Although TPPP is present
in multiple tissues, expression of TPPP is highest in the brain in
both mouse48 and human (Supplementary Fig. 12a). In GTEx
brain samples, high TPPP expression is accompanied by low
levels of linc00899, and in multiple sclerosis patients TPPP and
linc00899 expression were negatively correlated (Supplementary
Fig. 12b, c). This suggests that the regulatory relationship
observed in our study may be physiologically relevant in human
brain tissue and neuropathological diseases.
Gain-of-function and rescue studies of linc00899. Linc00089
could regulate TPPP expression in cis (locally) or in trans (dis-
tally), as shown for multiple lncRNAs3,5,49. Despite linc00089 and
TPPP being located on different chromosomes, a cis-acting
mechanism whereby lncRNA interacts with its target site by being
tethered to its site of synthesis cannot be excluded. To elucidate
the mode of action by which linc00899 regulates TPPP, we
compared the effects of ectopic and endogenous overexpression
of linc00899 on TPPP levels. Despite an increase in linc00899
expression after its ectopic overexpression using the expression
plasmid encoding linc00899 cDNA, no changes in TPPP levels
were observed in HeLa and RPE1 cells (Fig. 8a). These results
suggest that linc00899 is unlikely to function in trans to regulate
TPPP. Indeed, rescue experiments using expression plasmid after
RNAi- or LNA-mediated depletion of linc00899 failed to reduce
TPPP levels (Fig. 8b). Since linc00899 and TPPP are present on
different chromosomes, we tested the effect of linc00899 activa-
tion in the context of its normal genomic environment. For that
purpose, we employed the CRISPR activation (CRISPRa) sys-
tem50, which uses catalytically inactive dCas9 fused to tran-
scriptional activator VP64, and gRNAs targeting different regions
of the linc00899 promoter. We observed twofold overexpression
of linc00899 from its endogenous locus, which led to down-
regulation of TPPP in the normal diploid RPE1 but not in HeLa
cells (Fig. 8c). The lack of TPPP downregulation in HeLa cells
may stem from the presence of multiple linc00899 and TPPP
alleles; for instance, CRISPRa may not induce overexpression of
all (four or more) linc00899 loci. In summary, our data suggest
that linc00899 needs to be expressed from its own locus in order
to repress TPPP expression.
Linc0889 binds and regulates transcription of TPPP. As shown
in Fig. 2, linc00899 is a nuclear- and chromatin-enriched lncRNA,
raising the possibility that it could directly regulate transcription
of TPPP. To test this, we performed cleavage under targets and
release using nuclease (CUT&RUN)51 that allows genome-wide
profiling of active and repressive histone modifications as well as
transcription factors from low cell numbers. We observed an
increase in trimethylation of lysine 4 on histone H3 (H3K4me3),
a mark of active transcription, at the promoter of TPPP after
RNAi- and LNA-mediated depletion of linc00899 (Fig. 9a). Thus
elevated levels of TPPP mRNA in linc00899-depleted cells is likely
to arise from increased transcription at the TPPP locus. No sig-
nificant changes were seen in other active and repressive histone
modifications at the TPPP locus (Supplementary Fig. 13).
Based on these findings, we further hypothesised that linc00899
binds to regulatory regions of the TPPP locus. Therefore, we
performed capture hybridisation analysis of RNA targets with
sequencing (CHART-seq), a method used to identify lncRNA
binding sites on chromatin52–55. We first mapped antisense
oligonucleotides whose binding is accessible to linc00899 tran-
script (Supplementary Fig. 14a) and using the antisense cocktail
found approximately tenfold enrichment of linc00899 transcript
compared to the control oligonucleotides (Fig. 9b). No enrichment
upon pulldown was detected with the negative control transcript
5.8S. After sequencing the enriched genomic DNA using the
CHART-seq protocol56, we identified a prominent linc00899-
binding site in the intron of TPPP (Fig. 9c; Supplementary
Fig. 14b-d); however, we were not able to identify regions with
sequence complementarity to the linc00899 transcript (Supple-
mentary Fig. 15). Thus transcriptional upregulation of TPPP is
likely to be mediated by linc00899 binding to the TPPP locus
through protein interactions. This could occur through a 3D
proximity-guided localisation mechanism, which allows low-
abundant lncRNAs, such as linc00899, to identify its target genes
even on different chromosomes57. Such proximity-guided search
has been observed for Firre and CISTR-ACT lncRNAs58,59 and
could explain how linc00899, which is encoded on chromosome
22, may bind and regulate TPPP encoded on chromosome 5.
To corroborate that linc00899 act as a transcriptional repressor
of TPPP, we performed co-RNA FISH using intronic probes
against the premature TPPP and the mature linc00899 transcripts
(Fig. 9d). TPPP has eight alleles in the HeLa cell genome (https://
cansar.icr.ac.uk/cansar/cell-lines/HELA/copy_number_variation),
yet premature TPPP transcripts were detected only in one third of
the cells and presented mostly as a single focus. Approximately
3% of cells showed colocalisation between mature linc00899 and
premature TPPP transcript. Given that mature linc00899
transcripts can be detected in most cells, this low level of
colocalisation is consistent with effective linc00899-mediated
suppression of TPPP transcription.
Discussion
Previous studies have attributed the regulation of the cell cycle
primarily to multi-protein networks. Here we performed a high-
content imaging screen to identify lncRNAs with functions in cell
division. Development of in-house image analysis pipelines cou-
pled with targeted validation of lncRNA-induced phenotypes
allowed us to quantify the impact of lncRNA depletion on cell
division. Among other lncRNAs, this study identified linc00899
and C1QTNF1-AS1 as lncRNAs involved in the control of mitotic
progression.
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Our results revealed that linc00899 controls mitotic progression
by regulating TPPP, a protein that binds and stabilises the
microtubule network at all stages of the cell cycle35–38,48,60. TPPP
also binds to and inhibits histone deacetylase 6, an enzyme
responsible for tubulin deacetylation. This binding results in
increased tubulin acetylation36, a phenotype also observed upon
linc00899 depletion. Fine-tuning TPPP protein levels seems
particularly important for mitosis. Indeed, TPPP overexpression
in human cells suppresses microtubule growth velocity and
normal microtubule dynamics, thereby impeding timely spindle
assembly and cell division36. Previous studies have shown that
TPPP levels are subject to regulation by microRNAs61 and pro-
tein kinases48,60,62; our study now reveals lncRNA-mediated
transcriptional control as an additional regulatory layer.
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Fig. 7 Linc00899 regulates TPPP and mitotic progression in different cell lines. a Expression of linc00899 and TPPP after RNAi-mediated depletion of
linc00899 in normal retina cell line (hTert-RPE1) based on qPCR. Results are also shown for negative control siRNAs (Ctl, from Ambion) and cells treated
with transfection reagent alone (Cells). n= 3 biological replicates, *P < 0.05 and ****P < 0.0001 by two-tailed Student’s t test. b Quantification of mitotic
duration from time-lapse microscopy imaging after depletion of linc00899 in RPE1 cells. Number of cells analysed is n= 135 for Ctl si, n= 98 for Cells and
n= 103 for linc00899 RNAi. Data are shown as median with interquartile range from two biological replicates. ****P < 0.0001 by Mann–Whitney test.
c Expression of linc00899 and TPPP after RNAi-mediated depletion of linc00899 in non-tumorigenic epithelial breast cells (MCF10A). Controls are as
described in a. n= 3 biological replicates, *P < 0.05 and ****P<0.0001 by two-tailed Student’s t test. d Quantification of mitosis duration from time-lapse
microscopy imaging after depletion of linc00899 in MCF10A cells, as described in c. Number of cells analysed is n= 143 for Ctl si, n= 142 for Cells and
n= 63 for linc00899 siRNAs. Data are shown as median with interquartile range from two biological replicates. ****P < 0.0001 by Mann–Whitney test.
e Expression of linc00899 and TPPP after RNAi-mediated depletion of linc00899 in normal primary umbilical vein endothelial cells (HUVEC). Controls are
as described in a. n= 3–4 biological replicates, *P < 0.05 and **P < 0.01 by two-tailed Student’s t test. f Quantification of mitotic duration from time-lapse
microscopy imaging after depletion of linc00899 in HUVEC cells, as described in e. Number of cells analysed is n= 58 for Ctl si, n= 129 for Cells and
n= 181 for linc00899 RNAi. Data are shown as median with interquartile range from three biological replicates. ****P < 0.0001 by Mann–Whitney test.
Depletion of linc00899 in HUVEC, RPE1 and MCF10A leads to an ~8-, 12- and 16-min delay compared to cells treated with Ctl si, respectively. Data are
shown as mean ± S.E.M for a, c, e. Mitotic duration in b, d, f was defined from NEBD (t= 0min) to anaphase using bright-field microscopy. Source data are
provided as a Source Data file.
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Our mechanistic studies indicate that linc00899 regulates TPPP
transcription. In particular, this notion is supported by our
findings that (i) linc00899 is a nuclear and chromatin-enriched
lncRNA, (ii) linc00899 needs to be expressed from its own locus
in order to repress TPPP expression, (iii) H3K4me3 levels
increase at the TPPP promoter in linc00899-depleted cells, and
(iv) linc00899 binds at the TPPP genomic locus. It is possible that
linc00899 contributes to the repressive chromatin landscape at the
TPPP locus by altering local chromatin accessibility as observed
with other lncRNAs63. The mechanism whereby linc00899 binds
to the TPPP genomic locus and represses its transcription
remains to be fully defined. Given the limited colocalisation
between linc00899 and the premature TPPP transcript, it is more
likely that linc00899 uses “proximity-guided search” where tran-
scription site of linc00899 resides in close spatial proximity of
TPPP in the nucleus. This would allow linc00899 to act
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Fig. 8 Gain-of-function and rescue studies of linc00899 and its effect on TPPP expression. a Schematic diagram of ectopic overexpression of linc00899.
Linc00899 and TPPP expression were analysed by qPCR after lentiviral overexpression using lincXpress vector encoding linc00899 cDNA in HeLa (left) and
RPE1 cells (right). The expression was normalised to the scrambled linc00899 vector (negative control). n= 3–4 biological replicates, *P < 0.05 by two-
tailed Student’s t test. b Rescue of linc00899 function after RNAi- or LNA-mediated depletion of linc00899 in HeLa cells through ectopic overexpression of
linc00899. n= 3 biological replicates, *P < 0.05, **P < 0.01 and ****P < 0.0001 by two-tailed Student’s t test. c Schematic diagram of endogenous
overexpression of linc00899 using CRISPRa. Linc00899 and TPPP expression were analysed by qPCR after transduction of dCas9-VP64 and gRNAs
targeting different regions of the linc00899 promoter in HeLa (left) and RPE1 cells (right). The expression was normalised to the negative guide (negative
control). n= 4 biological replicates, *P < 0.05, ***P < 0.001 and ****P < 0.0001 by two-tailed Student’s t test. Data are shown as mean ± S.E.M for
a–c. Source data are provided as a Source Data file.
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immediately upon its transcription and suppress TPPP expression
possibly via interactions with protein complexes, such as chro-
matin regulators57. It is also possible that the linc00899-mediated
regulation of TPPP transcription depends on linc00899 release
from the chromatin, with linc00899 target specificity being guided
by the pre-established chromosomal proximity, as shown for
lncRNA A-ROD64. As we did not observe a strong sequence
complementarity between the linc00899 transcript and the TPPP
DNA sequence, we excluded the possibility of direct binding of
linc00899 to TPPP locus. Instead, our data suggest that the
linc00899 function could be mediated through linc00899–protein
interactions. Further studies will be required to determine the
in vivo linc00899–protein interactome and the relevance of these
interactions in TPPP transcriptional regulation and cell division.
TPPP is crucial for microtubule organisation in the brain and
for local microtubule nucleation and myelin sheath elongation65.
In Drosophila, TPPP mutants (also known as Ringmaker) exhibit
defects in axonal extension66. In mammals, it is primarily
expressed in oligodendrocytes where it stabilises microtubule
networks, and its depletion in progenitors inhibits oligoden-
drocyte differentiation61. Indeed, TPPP-deficient mice display
convulsive seizures and motor coordination deficits65 due to
hypomyelination in multiple brain regions, consistent with a
defect in myelinating oligodendrocytes67.
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In humans, an inverse correlation between TPPP and linc00899
across all tissues is consistent with a regulatory relationship, with
the highest expression of TPPP (and lowest expression of
linc00899) being observed in the brain. This suggests that
linc00899-dependent suppression of TPPP could be used to fine-
tune TPPP expression and hence microtubule behaviour in a
developmental stage- and tissue-specific manner. Intriguingly,
altered TPPP protein levels have been observed in a number of
neurodegenerative disorders, including multiple sclerosis and
Parkinson’s disease68,69.
In this study, we have comprehensively explored the activity of
thousands of lncRNAs in cell cycle regulation and identified an
assortment of lncRNAs that are involved in controlling mitotic
progression, chromosome segregation and cytokinesis. While our
analysis encompassed several cellular features, the imaging data
from our screen allows us to extract phenotypes at any stage of
cell division upon lncRNA depletion. As interest in the regulatory
functions of lncRNAs increases, we anticipate that our data will
serve as a powerful resource for prioritising lncRNA candidates
for further studies in the RNA and cell cycle fields.
Methods
Cell lines and reagents. HeLa and 293FT cells were maintained in Dulbecco’s
modified Eagle’s medium (DMEM; Gibco, 41966-029) supplemented with 10%
foetal bovine serum (FBS; Thermo Fisher Scientific, 10500064). HeLa cell line was
chosen for this study as majority of phenotypic screens, which identified protein-
coding genes in cell division, have been performed in HeLa cells (e.g. Mito-
Check18). MCF10A (human breast epithelial cell line) were cultured in Mammary
Epithelial Cell Growth Medium (Lonza, CC-3151) with supplements and growth
factors (Lonza, CC-4136). HUVECs (CC2517, LOT 0000482213) were maintained
in Endothelial Cell Growth Medium Lonza (Lonza, CC-3121) with supplements
and growth factors (Lonza, CC-4133). RPE1 cells were maintained in Dulbecco’s
modified Eagle’s medium F12 Nutrient Mixture (Gibco, 31331-028) supplemented
with 10% FBS (Thermo Fisher Scientific, 10500064, LOT 2025814K). All cell lines
were obtained from the American Type Culture Collection (ATCC) and were
cultured at 37 °C with 5% CO2. HeLa Kyoto (EGFP-α-tubulin/ H2B-mCherry) cells
were obtained from ATCC/Jan Ellenberg (EMBL Heidelberg)18 and cultured in
DMEM with 10% FBS. All cell lines were verified by short tandem repeat profiling
and tested negative for mycoplasma contamination. Paclitaxel (taxol) used in cell
culture experiments was dissolved in dimethyl sulfoxide (DMSO; T7402, Sigma)
and used at final concentrations of 0.5 or 3 nM. The cells were treated for 1 or 20 h.
Final concentration of DMSO in media was 0.05%.
High-content imaging screen: Lincode siRNA library. The Lincode siRNA
Library (GE Dharmacon, G-301000) is a collection of siRNA reagents targeting
2231 human lncRNAs (1860 unique human lncRNA genes and 371 lncRNA
transcripts associated with protein-coding genes). The design of this library is
based on RefSeq version 54 and the siRNAs are arrayed as SMARTpools. The
library was purchased at 0.1 nmol in a 96-well format. The library was diluted to a
5 μM stock with 1× siRNA buffer (GE Dharmacon, B-002000-UB-100) and arrayed
onto black 384-well PerkinElmer Cell Carrier plates (Perkin Elmer, 6007550) using
the Echo Liquid Handler (Labcyte). The black 384-well PerkinElmer Cell Carrier
plates were prepared in advance and stored at −80 °C. The final siRNA con-
centration per well was 20 nM. An siRNA targeting exon 1 of lncRNA GNG12-AS1
(Silencer select, Life Technologies, S59962)70 and SMARTpool siRNAs targeting
protein-coding gene CKAP5/Ch-TOG (GE Dharmacon, L-006847-00) were also
included on each plate. CKAP5/Ch-TOG was used as a positive control as its
depletion leads to mitotic delay and increased mitotic index24. ECT2 SMARTpool
siRNAs (GE Dharmacon, L-006450-00-0005) were used as a positive control in the
third validation screen as its depletion results in multinucleated cells26.
High-content imaging screen: reverse transfection. To redissolve the siRNA in
the black 384-well PerkinElmer Cell Carrier plates (10 plates in total), 5 μl of
OptiMEM medium (Thermo Fisher Scientific, 31985047) was added. The plates
were centrifuged (1 min, 900 × g) and incubated at room temperature (RT) for
5 min. Lipofectamine RNAimax (Thermo Fisher Scientific, 13778150) was added in
OptiMEM medium to a final concentration of 8 μl Lipofectamine to 1 ml Opti-
MEM medium and incubated at RT for 5 min. Five μl of OptiMEM/Lipofectamine
mix was then added to the plates. Plates were centrifuged and incubated at RT for
20 min. In the meantime, HeLa cells were trypsinised and counted using an
automated cell counter (Countess, Thermo Fisher Scientific). Cells were cen-
trifuged at 1000 × g for 4 min, the medium was removed and the cells were
resuspended in OptiMEM medium to a final concentration of 2000 cells/well. Ten
μl of cell suspension was added to the plates, and plates were centrifuged and
incubated at 37 °C for 4 h, before adding 10 μl of DMEM+30% FBS+3% P/S
(penicillin/streptomycin, P/S) (final concentration 10% FBS, 1% P/S). Plates were
centrifuged and incubated at 37 °C for 48 h before fixation. A Multidrop Combi
Reagent dispenser (Thermo Fisher Scientific) was used throughout the transfection
protocol to ensure even liquid addition.
High-content imaging screen: fixation and immunostaining. For screen A, the
plates were fixed by adding an equal volume of pre-warmed (37 °C) 8% for-
maldehyde (Thermo Fischer Scientific, 28908)/phosphate-buffered saline (PBS)
solution to the wells and incubated at 37 °C for 10 min. The cells were permea-
bilised with pre-warmed PBS/0.2% Triton X-100 (Acros Organics, 327371000) for
15 min at RT. The cells were then blocked in 1% bovine serum albumin (BSA)/PBS
for 1 h at RT. To perform the immunostaining, the cells were incubated with
primary antibodies against α-tubulin (Dm1α, Sigma, TUB9026, dilution 1:1000),
CEP215/CDK5RAP271 (dilution 1:500) and Alexa-Fluor® 568 Phalloidin (Thermo
Fisher Scientific, A12380, dilution 1:500) for 2 h at RT. The cells were washed three
times in 1× PBS and incubated for 1 h at RT with secondary antibodies Alexa
Fluor® 488 (Thermo Fisher Scientific, A21206, dilution 1:1000) and Alexa Fluor®
647 (Thermo Fisher Scientific, A31571, dilution 1:1000). After three washes in 1×
PBS, the cells were incubated with 1 µg/ml Hoechst (Sigma, H 33258, diluted in
PBS) for 15 min at RT before a final wash in 1× PBS and imaging.
For screen B, the same fixation protocol as described for screen A was used. For
permeabilisation, PBS/0.05% sodium dodecyl sulfate was used for 20 min at RT.
Blocking was performed as described above. For the immunostaining, cells were
incubated with primary antibodies against γ-tubulin (Sigma, GTU88, dilution
1:1000) and phospho-histone H3 serine 10 (PHH3, Millipore, 06-570, dilution
1:2000) for 2 h at RT and washed three times with 1× PBS before incubation with
secondary antibodies (Thermo Fisher Scientific, A-31571 and A-21206, both at
dilution 1:1000). After three 1× PBS washes, the cells were stained with α-tubulin
(Serotec, MCA78G, dilution 1:500) and incubated with secondary antibody
(Thermo Fisher Scientific, A-21434, dilution 1:1000). All primary and secondary
antibodies were diluted in 1% BSA/PBS. The fixation and staining for both
replicates was carried out at the Institute for Cancer Research (ICR, London) using
the PerkinElmer Cell:Explorer system coupled to automated liquid handling
equipment. Solutions were dispensed using a Multidrop Combi Reagent dispenser
(Thermo Fisher Scientific) and aspirated/washed using a Biotek washer with 96
pins. All plates were imaged using the PerkinElmer Opera high-content confocal
screening platform with spinning disc. Thirty fields of view per well were captured
using a ×20 air objective, numerical aperture (NA) 0.45.
High-content imaging screen: image analysis. All image analysis was performed
using custom workflows created with the Columbus software (PerkinElmer).
Several output parameters were evaluated from high-content images: mitotic index
(number of cells in mitosis), multinucleation index (number of multinucleated
cells), number of viable cells, number of chromosome segregation errors (chro-
matin bridges and lagging chromatids) and number of cells with cytokinetic
bridges (Supplementary Fig. 1). These are defined in more detail below.
Mitotic and multinucleation index. Nuclei were first segmented using Hoechst
staining (which defines the total cell number). The false positives (e.g. dead cells)
were discarded based on the nucleus area, α-tubulin and γ-tubulin/
CEP215 staining intensity. Multinucleated non-dividing cells were retained as a
separate subpopulation using a two-step detection process: binucleated cells were
isolated using size, aspect ratio and roundness parameters of close nucleus pairs.
Other multinucleated cells were then identified among remaining cells for which α-
or γ-tubulin intensity was low in the perinuclear region. Further identification of
mitotic cells/stages was accomplished using filters based on Hoechst for the nucleus
shape and size, in combination with high PHH3 (screen B) or high α-tubulin and
low CEP215 staining intensity (screen A). Notably, nuclei of cells in anaphase/
telophase stage of mitosis were small, had elongated shape and exhibited low
Hoechst integrated intensity (low amount of DNA among mitotic cells). The
distance between both nuclei of cells in anaphase/telophase stage was the main
criteria to discard two daughter non-mitotic cells (maximum of 0.65 and 2.6 µm,
respectively). From all these sub-populations, we calculated mitotic and multi-
nucleation index relative to the total number of live cells.
Chromosome segregation errors. We started from the previous identified sub-
population of cells in anaphase/telophase stage. We filtered cells according to α-
tubulin staining intensity between nuclei, as cells in anaphase have lower α-tubulin
intensity compared to the cells in telophase. This allowed us to identify only the
cells in anaphase. To calculate the number of anaphase cells with chromosome
segregation errors, the inter-nuclei space was used as the measuring area to cal-
culate the remaining Hoechst signal. This captures both chromatin bridges and
lagging chromatids.
Number of viable cells. The total number of viable cells was determined after
removal of dead cells and cell debris with anaphase and telophase cells counted as
one (despite exhibiting two nuclear segments). The same rule was applied for
multinucleated cells.
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Number of cytokinetic bridges. Cytokinetic bridges were defined as elongated
high-intensity objects split into two parts that are positive for α-tubulin staining.
We used prior segmentation of the cytoplasm and the Spot Finder feature to
identify bridge half parts and sorted them as doublets by calculating the distance
between them. We discarded the false positive candidates based on the shape
criteria and γ-tubulin staining. The final number of cytokinetic bridges was divided
by the total number of viable cells.
To minimise the variation in the cell density between different wells among all
ten 384-well plates, we divided the output numbers by the total number of cells per
well (dead cells were not included). Multinucleated cells were considered to be
single cells during counting. The ratios were then normalised between screen plates
by calculating the average value per plate and finally the grand average of all ten
plates, giving a reference mean ratio. Per-well ratios were scaled so that the per-
plate average was equal to the reference. Z-scores (z) were calculated as follows for
each parameter:
z ¼ ðx  μÞ=σ ð1Þ
where x represents the ratio for the feature of interest (e.g. mitotic/multinucleation
index), μ represents the reference ratio and σ represents the standard deviation of
ratios across wells. All the scripts used for the image analysis are available at
https://github.com/MarioniLab/LncScreen2018.
High-content imaging screen: third-pass validation screen. The third-pass
validation screen was performed in two replicates with four technical replicates
using the top 25 candidates from each of the categories (mitotic progression,
cytokinesis) using the same antibodies as in screen B. Correlation coefficients
between replicate plates in third screen were calculated by Spearman’s rank cor-
relation (mitotic index= 0.967888, viability= 0.93249, multinucleation index=
0.995897, cytokinetic bridges= 0.898324).
Single-molecule RNA FISH. Cells were grown on coverslips in 12-well plates,
briefly washed with 1× PBS and fixed with PBS/3.7% formaldehyde at RT for
10 min. Following fixation, cells were washed twice with PBS. The cells were then
permeabilised in 70% ethanol for at least 1 h at 4 °C. Stored cells were briefly
rehydrated with Wash Buffer (2× SSC, 10% formamide, Biosearch) (Formamide,
Thermo Fischer Scientific, BP227-100) before FISH. The Stellaris FISH Probes
(linc00899 and C1QTNF1-AS1 exonic probes Q570) were added to the hybridisa-
tion buffer (2× SSC, 10% formamide, 10% dextran sulfate, Biosearch) at a final
concentration of 250 nM. Hybridisation was carried out in a humidified chamber at
37 °C overnight. The following day, the cells were washed twice with Wash Buffer
(Biosearch) at 37 °C for 30 min each. The second wash contained 4,6-diamidino-2-
phenylindole for nuclear staining (5 ng/ml, Sigma, D9542). The cells were then
briefly washed with 2× SSC and then mounted in Vectashield (Vector Laboratories,
H-1000). Images were captured using a Nikon TE-2000 inverted microscope with
the NIS-elements software, a Plan Apochromat ×100 objective and an Andor Neo
5.5 sCMOS camera. We acquired 25 optical slices at 0.3-µm intervals. Images were
projected in two dimensions using ImageJ and deconvolved with Huygens
Professional.
For validation of CHART-sequencing, Stellaris FISH Probes for intronic region
of TPPP (Q670) were combined with linc00899 exonic probe (Q570) at a final
concentration of 250 nM per probe set. To score whether TPPP (intronic signal)
and linc00899 (exonic signal) colocalize, we only considered cells in which both
signals were present. The sequences of RNA FISH probes are presented in
Supplementary Data 4.
Plasmids. To insert pAS into lncRNAs, pSpCas9(BB)−2A-GFP vector was used
(PX458, Addgene, #48138). For CRISPR activation (CRISPRa), pHAGE EF1alpha
dCAS-VP64-HA (Addgene, #50918), pU6-sgRNA EF1Alpha-puro-T2A-BFP
(Addgene, #60955), second-generation packaging plasmid psPAX2 (Addgene,
#12260) and the envelope plasmid pMD2.G (Addgene, #12259) were used.
Linc00899 and C1QTNF1-AS1 constructs were synthesised by Labomics. The full
sequence of linc00899 was synthesised as CS-LNC233J-T7 (4283 bp, insert was
1610bp based on NR_027036), scrambled linc00899 was CS-LNC236J-T7, full
C1QTNF1-AS1 was CS-LNC237JT7 (3638 bp, insert was 970 bp based on
NR_040018) and scrambled C1QTNF1-AS1 was CS-LNC238JT7). Sequences of
Labomics lncRNA vectors (pUCLOMT) are presented in Supplementary Methods.
RNA isolation, cDNA synthesis and qPCR. RNA (1 µg) was extracted with the
RNeasy Kit (QIAGEN, 74106) and treated with DNase I following the manu-
facturer’s instructions (QIAGEN, 79254). The QuantiTect Reverse Transcription
Kit (QIAGEN, 205313) was used for cDNA synthesis including an additional step
to eliminate genomic DNA contamination. qPCR was performed on a QuantStudio
6 Flex (Thermo Fischer Scientific) with Fast SYBR Green Master Mix (Life
Technologies). Thermocycling parameters were defined as 95 °C for 20 s followed
by 40 cycles of 95 °C for 1 s and 60 °C for 20 s. Two reference genes (GAPDH and
RPS18) were used to normalise expression levels using the 2−ΔΔCT method.
Sequences of qPCR primers are provided in Supplementary Table 1. For linc00899
and C1QTNF1-AS1 primers against exons 2–4 and 1–2, respectively, were used
throughout the paper if not indicated otherwise.
siRNA and LNA depletion experiments. HeLa cells were transfected with Lipo-
fectamine RNAiMax reagent (Thermo Fischer Scientific) following the manu-
facturer’s instructions. All experiments were done 48 h after transfection. The pool
of four siRNA sequences (SMARTpool, Thermo Fischer Scientific) and LNA
Gapmers (Exiqon) were used at a final concentration of 50 and 25 nM, respectively.
For double knockdown experiments, HeLa cells (10,000 cells/well) were plated on
8-well chamber slides (Ibidi, 80826) for time-lapse microscopy imaging or in 6-well
for RNA extraction (Corning, 120,000 cells/well). The cells were transfected the
next day with either negative control siRNA (Ctl, from Ambion), a SMARTpool of
siRNAs targeting linc00899 or TPPP or siRNAs targeting linc00899 in combination
with TPPP. The same final concentration of 50 nM was achieved for both single
and double knockdown by adding equal amount of control siRNA sequence (Ctl)
to the single SMARTpool targeting linc00899 or TPPP separately. siRNA and LNA
sequences are listed in Supplementary Tables 2 and 3, respectively.
Western blot analysis. Cells were grown in a six-well plate, trypsinised, pelleted
and washed twice with 1× PBS. The pellet was lysed in lysis buffer (50 mM Tris-
HCl, pH 8, 125 mM NaCl, 1% NP-40, 2 mM EDTA, 1 mM PMSF [Sigma, 93482-
50ML-F] and protease inhibitor cocktail [Roche, 000000011836170001]) and
incubated on ice for 25 min. The samples were centrifuged for 3 min at 12,000 × g
and 4 °C. Supernatant was collected and protein concentration was determined
using the Direct Detect® Spectrometer (Merck Millipore). The proteins (30 µg)
were denatured, reduced, and separated with Bolt® 4–12% Bis-Tris Plus Gel
(Thermo Fisher Scientific, NW04120BOX) in MOPS buffer (Thermo Fisher Sci-
entific, B0001-02). Precision Plus Protein Standards (161-0373, Bio-Rad) was used
as a protein standard. The proteins were then transferred to nitrocellulose mem-
brane and blocked with 5% nonfat milk in TBS-T (50 mM Tris, 150 mM NaCl,
0.1% Tween-20) for 1 h at RT. The membranes were incubated with primary
antibodies in 5% milk in TBS-T with the following antibodies: TPPP/p25 (NBP2-
34031, Novus, dilution 1:1000), β-tubulin (T019, Sigma, dilution 1:2000), p150
(610473, BD Transduction Laboratories, dilution 1:2000), Cyclin B1 (12231S, Cell
signalling, dilution 1:1000), RAI14 (NBP1-94075, Novus, dilution 1:300), DNAAF5
(HPA020243, Atlas Antibodies, dilution 1:250), ITGB1BP1 (HPA071538, Atlas
Antibodies, dilution 1:250), and phospho Histone H3 serine 10 (06-570, Millipore,
dilution 1:1000). After overnight incubation at 4 °C, the membranes were washed
with TBS-T and incubated with horseradish peroxidase secondary antibodies (GE
Healthcare Life Sciences, 1:2000), and immunobands were detected with a Pierce
ECL Western Blotting Substrate (Thermo Fischer Scientific, 32106). Quantification
of immunoblots normalised against appropriate loading controls was done using
ImageJ. Uncropped scans of the immunoblots are provided in the Source Data file.
The list of all primary and secondary antibodies is provided in Supplementary
Table 4.
Time-lapse microscopy imaging. HeLa (10,000 cells/well), HeLa Kyoto (10,000
cells/well), RPE1 (10,000 cells/well), MCF10A (15,000 cells/well) and HUVEC cells
(15,000 cells/well) were cultured in 8-well chamber slides (Ibidi) with 200 μl/well of
the corresponding medium. Imaging was performed in their corresponding med-
ium. Time-lapse microscopy imaging was performed for all cell lines 48 h after
transfection with RNAi or LNA gapmers. Mitotic duration was measured as the
time from nuclear envelope breakdown until anaphase onset, based on visual
inspection of the images. Cytokinesis was measured from anaphase onset to
abscission completion. Live-cell imaging was performed using a Zeiss Axio
Observer Z1 microscope equipped with a PL APO 0.95NA ×40 dry objective (Carl
Zeiss Microscopy) fitted with a LED light source (Lumencor) and an Orca Flash 4.0
camera (Hamamatsu). Four positions were placed per well and a z-stack was
acquired at each position every 10 min (HeLa, HeLa Kyoto) or 5 min (MCF10A,
HUVEC, RPE1) for a total duration of 12 h. To detect chromosome segregation
errors (chromatin bridges and/or lagging chromatids), HeLa Kyoto cells were
imaged every 4 min with only 2 positions/well. Voxel size was 0.325 µm × 0.325
µm × 2.5 µm. Zen software (Zeiss) was used for data collection and analysis.
Throughout the experiment, cells were maintained in a microscope stage incubator
at 37 °C in a humidified atmosphere of 5% CO2.
Cell cycle synchronisation. HeLa cells were grown to 50% confluency and then
synchronised with thymidine for 16 h (2 mM, Sigma, T1895). The cells were
washed three times with 1× PBS and then released into thymidine-free medium for
5 h. The cells were released for the indicated timepoints for RNA collection.
Treatment of HeLa cells with monastrol (100 µM for 16 h; Tocris, 1305) coupled
with the mitotic shake-off was used to isolate mitotic cells.
Copy number evaluation. To calculate the linc00899 and C1QTNF1-AS1 copy
number, a standard curve of Ct values was generated by performing qPCR on a
dilution series of known concentration of linc00899 or C1QTNF1-AS1 DNA
templates (Labomics). cDNA was prepared from RNA (1 µg) extracted from the
known number of HeLa cells (500,000 cells). The observed Ct values were fitted on
the standard curve and the number of lncRNA molecules per cell was calculated.
The final value was multiplied by 2 to account for the fact that cDNA is single
stranded and DNA templates used to make the standard curve were double
stranded.
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RNA library preparation, sequencing and analysis. RNA-seq libraries were
prepared from HeLa cells using TruSeq Stranded Total RNA Kit with Ribo-Zero
Gold (Illumina, RS-122-2303). We generated four biological replicates for RNAi-
and LNA-mediated depletion of linc00899 and C1QTNF1-AS1. Indexed libraries
were PCR-amplified and sequenced using 125 bp paired-end reads on an Illumina
Hiseq 2500 instrument (CRUK CI Genomics Core Facility). Each library was
sequenced to a depth of 20–30 million read pairs. Paired-end reads were aligned to
the human genome hg38 with subread and the number of read pairs mapped to the
exonic regions of each gene was counted for each library by using the feature-
Counts72 function in Rsubread v1.30.0 with Ensembl GRCh38 version 91. Only
alignments with mapping quality scores >10 and with the first read pair on the
reverse strand were considered during counting. Approximately 80% of read pairs
contained one read that was successfully mapped to the reference, and 74% of all
read pairs in each library were assigned into exonic regions. Any outlier samples
with very low depth (resulting from failed library preparation or sequencing) were
removed prior to further analysis.
The DE analysis was performed using the limma package v3.36.073. First, lowly
expressed genes with average counts <3 were filtered out. Normalisation was
performed using the trimmed mean of M-values (TMM) method to remove
composition biases. Log-transformed expression values with combined precision/
array weights were computed with the voomWithQualityWeights function74. The
experimental design was parametrised using an additive model with a group factor,
where each group was comprised of all samples from one batch/treatment
combination, and an experiment factor, representing samples generated on the
same day. Robust empirical Bayes shrinkage75 was performed using the eBayes
function to stabilise the variances. Testing for DEGs was performed between pairs
of groups using the treat function76 with a log-fold change threshold of 0.5. Here
the null hypothesis was that the absolute log2-fold change between groups was
≤0.5. All pairwise contrasts involved groups from the same batch to avoid spurious
differences due to batch effects. For each contrast, genes with significant differences
in expression between groups were detected at an false discovery rate (FDR) of 5%.
To identify DEGs that were consistent across LOF methods, an intersection–union
test was performed77 on one-sided P values in each direction, followed by an FDR
correction. Coverage tracks for each library were generated using Gviz as
previously described.
CHART sequencing and analysis. CHART enrichment and RNase H (NEB,
M0297S) mapping was performed as previously described52,56. Briefly, five 150-
mm dishes of HeLa cells were used to prepare the CHART extract for each pull-
down. In the first sonication step, the samples were sonicated using Covaris S220
(Covaris, 500217) in microTUBEs (Covaris, 520045) in a final volume of 130 µl
(Programme conditions: 20% duty cycle, 200 bursts/cycle, Intensity 175, 8 min).
The extracts were hybridised with a linc00899 oligonucleotide cocktail (mix of 4
oligos used at final concentration of 25 µM) overnight at RT. MyOne streptavidin
beads C1 (Thermo Fischer Scientific, 65001) were used to capture complexes
overnight at RT by rotation. Bound material was washed five times and RNase H
(NEB) was added for 30 min at RT to elute RNA–chromatin complexes. To
increase recovery yield, the remaining beads were saved and the bound material
was eluted with Proteinase K (Thermo Fischer Scientific, 25530-049) in 100 µl of
XLR buffer for 60 min at 55 °C. The supernatant was then collected and heated for
additional 30 min at 65 °C. The RNase H eluate samples were also treated with
Proteinase K (Thermo Fischer Scientific, 25530-049) and cross-links were reversed
(55 °C for 1 h, followed by 65 °C for 30 min). One fifth of the total sample was used
to purify RNA using the miRNeasy Kit (QIAGEN, 217004) and to calculate RNA
enrichment, while the rest of the sample was used to purify DNA using Phenol-
ChCl3:isoamyl (Thermo Fischer Scientific, 15593-031) extraction and ethanol
precipitation. The final CHART DNA was eluted in 12.5 µl of 1× TE buffer (low
EDTA, pH 7.4). Ten µl from this reaction was used for sonication using Covaris
LE220 (programme 250 bp/10 s) to obtain average fragment size of 200–300 bp. For
this, microTUBE-15 beads strips (520159, Covaris) were used in a total volume of
15 µl. After sonication, the DNA was measured by Nanodrop (input, diluted 1:20)
and Qubit High Sensitivity DNA Assay (eluates were undiluted). CHART material
(5 ng) was used for library preparation using the ThruPLEX DNA-Seq library
preparation protocol (Rubicon Genomics, UK). For inputs, six PCR cycles were
performed, while for eluates eight PCR cycles were performed owing to the lower
quantity of input DNA. Library fragment size was determined using a 2100
Bioanalyzer (Agilent). Libraries were quantified by qPCR (Kapa Biosystems).
Pooled libraries were sequenced on a HiSeq4000 (Illumina) according to the
manufacturer’s instructions to generate paired-end 150 bp reads (CRUK CI
Genomics Core Facility). CHART-seq was performed from five biological replicates
using a mix of two sense control oligos for linc00899 as a negative control for the
linc00899 pulldown. Reads were aligned to the hg38 build of the human genome
using subread in paired-end genomic mode. A differential binding (DB) analysis
was performed using csaw to identify lncRNA-binding sites in the pulldown
compared to the sense control. Filtered windows were obtained as described for the
CUT&RUN data analysis. Normalisation factors were computed by binning read
pairs into 5-kbp intervals and applying the TMM method without weighting, to
account for composition biases from greater enrichment in the antisense pulldown
samples. The filtered windows and normalisation factors were then used in a DB
analysis with the quasi-likelihood framework in edgeR. This was performed using
an additive design for the generalised linear model fit, containing terms for the
batch and the pulldown (five batches in total, sense and antisense pulldowns in
each batch). A P value was computed for each window by testing whether the
pulldown term was equal to zero, i.e. no difference in coverage between the anti-
sense pulldown and sense control. The above analysis was repeated using window
sizes from 150 to 1000 bp to obtain DB results at varying resolutions. These results
were consolidated into a single list of DB regions using consolidateWindows as
previously described, yielding a combined P value for each region. The combined P
values across all regions were then used to compute the empirical FDR (eFDR),
defined as the ratio of the number of clusters that exhibited increased coverage in
the sense control (i.e. false positives) to the number of clusters with increased
coverage in the antisense pulldown (i.e. potentially true discoveries). Putative
lncRNA-binding sites were defined at an eFDR of 30%. Coverage tracks for each
library were generated using Gviz as previously described. The list of CHART
probes and CHART primers is provided in Supplementary Tables 5 and 6,
respectively.
CUT&RUN (cleavage under targets and release using nuclease). Chromatin
profiling was performed according to Skene et al.51 with minor modifications.
HeLa cells were plated in 30-mm dishes (220,000 cells/dish) and transfected the
next day with either negative control siRNA, linc00899 siRNA pool, negative
control LNA A or an LNA gapmer targeting linc00899 (LNA1). Two biological
replicates were performed per condition. Cells were washed once with PBS, spun
down at 600 × g for 3 min in swinging-bucket rotor and washed twice with 1.5 ml
Wash buffer (20 mM HEPES-KOH (pH 7.5), 150 mM NaCl, 0.5 mM Spermidine
and 1× cOmplete™ EDTA-free protease inhibitor cocktail (Roche)). During the cell
washes, concanavalin A-coated magnetic beads (Bangs Laboratories, BP531) (10 µl
per condition) were washed twice in 1.5 ml Binding Buffer (20 mM HEPES-KOH
(pH 7.5), 10 mM KCl, 1 mM CaCl, 1 mMMnCl2) and resuspended in 10 µl Binding
Buffer per condition. Cells were then mixed with beads and rotated for 10 min at
RT, and samples were split into aliquots according to the number of antibodies
profiled per cell type. We used 80–100,000 cells per chromatin mark. Cells were
then collected on magnetic beads and resuspended in 50 µl Antibody Buffer (Wash
buffer with 0.05% Digitonin and 2 mM EDTA) containing one of the following
antibodies in 1:100 dilution: H3K4me3 (Millipore 05-1339 CMA304, Lot 2780484),
H3K27me3 (Cell Signaling #9733 S C36B11, Lot 8), H3K36me3 (Active Motif
Cat#61101, Lot 32412003), H3K27ac (Abcam ab4729, Lot GR3211741-1) and Goat
Anti-Rabbit IgG H&L (Abcam ab97047, Lot GR254157-8). Cells were incubated
with antibodies overnight at 4 °C rotating, and then washed once with 1 ml
Digitonin buffer (Wash buffer with 0.05% Digitonin). For the mouse anti-
H3K4me3 antibody, samples were incubated with 50 µl of a 1:100 dilution in
Digitonin buffer of secondary rabbit anti-mouse antibody (Invitrogen, A27033, Lot
RG240909) for 10 min at RT and then washed once with 1 ml Digitonin buffer.
Samples were then incubated in 50 µl Digitonin buffer containing 700 ng/ml
Protein A-MNase fusion protein (kindly provided by Steven Henikoff) for 10 min
at RT followed by two washes with 1 ml Digitonin buffer. Cells were then resus-
pended in 100 µl Digitonin buffer and cooled down to 4 °C before addition of
CaCl2 to a final concentration of 2 mM. Targeted digestion was performed for
30 min on ice until 100 µl of 2× STOP buffer (340 mM NaCl, 20 mM EDTA, 4 mM
EGTA, 0.02% Digitonin, 250 mg RNase A, 250 µg Glycogen, 15 pg/ml yeast spike-
in DNA (kindly provided by Steven Henikoff)) was added. Cells were then incu-
bated at 37 °C for 10 min to release cleaved chromatin fragments, spun down for 5
min at 16,000 × g at 4 °C and collected on magnet. Supernatant containing the
cleaved chromatin fragments were then transferred and cleaned up using the Zymo
Clean & Concentrator Kit. Library preparation78 was performed using the Thru-
PLEX® DNA-Seq Library Preparation Kit (Rubicon Genomics) with a modified
library amplification programme: extension and cleavage for 3 min at 72 °C fol-
lowed by 2 min at 85 °C, denaturation for 2 min at 98 °C followed by four cycles of
20 s at 98 °C, 20 s at 67 °C, and 40 s at 72 °C for the addition of indexes. Ampli-
fication was then performed for 12 cycles of 20 s at 98 °C and 15 s at 72 °C (14
cycles were used for the Goat Anti-Rabbit antibody due to the lower yield of input
DNA). Double-size selection of libraries was performed using Agencourt AMPure
XP beads (Beckman Coulter, A63880) according to the manufacturer’s instruc-
tions. Average library size was determined using an Agilent Tapestation DNA1000
High Sensitivity Screentape and quantification was performed using the KAPA
Library Quantification Kit. CUT&RUN libraries were sequenced on a HiSeq2500
using a paired-end 125 bp run at the CRUK CI Genomics Core Facility. Reads were
aligned to a reference genome containing the hg38 build of the human genome and
the R64 build of the yeast genome, using subread v1.6.179 in paired-end genomic
mode. A DB analysis was performed using the csaw package v1.14.080 to identify
changes in histone mark enrichment in linc00899-depleted cells compared to the
negative controls for each LOF method. Coverage was quantified by sliding a
window across the genome and counting the number of sequenced fragments
overlapping the window in each sample. Windows were filtered to retain only those
with average abundances that were fivefold greater than the expected coverage due
to background non-specific enrichment. Normalisation factors were computed by
applying the TMM method81 without weighting to the filtered windows. The fil-
tered windows and normalisation factors were then used in a DB analysis with the
quasi-likelihood framework in the edgeR package v3.22.082. This was performed
using an additive design for the generalised linear model fit, containing terms for
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the batch and the depletion status (two batches in total, depletion and negative
control from LNA and RNAi in each batch). A P value was computed for each
window by first testing whether for a depletion effect in each LOF method and then
taking the larger of the two P values77 across both LOF methods. The above
analysis was repeated using window sizes from 150 to 1000 bp to obtain DB results
at varying resolutions. To consolidate these results into a single list of DB regions,
overlapping windows of all sizes were clustered together based on their genomic
locations, using a single-linkage approach in the consolidateWindows function. For
each cluster of windows, a combined P value was computed using Simes’ method83.
This represents the evidence against the global null hypothesis for each cluster, i.e.
that none of the constituent windows are DB. The Benjamini–Hochberg method
was used to define putative DB regions at an FDR of 5%. Coverage tracks were
generated by computing the number of sequencing fragments per million over-
lapping each based, using library sizes adjusted according to the TMM normal-
isation factors for each library. Tracks were visualised using the Gviz package84.
Generation of C1QTNF1-AS1 CRISPR poly(A) site clones. Insertion of the
transcriptional termination signal pAS34 into the first exon of C1QTNF1-AS1 was
performed using a published CRISPR/CAS9 protocol85. Briefly, the CRISPR pAS
guide oligonucleotides were phosphorylated (T4 poly nucleotide kinase; NEB),
annealed and ligated (Quick Ligase Kit, NEB) into BbsI (NEB) digested pX458
vector (Addgene, #48138). The oligonucleotides (Sigma-Aldrich, diluted in low TE
EDTA buffer at 100 µM) used for the gRNA target sequence are listed in Sup-
plementary Table 7. All inserts were verified with Sanger sequencing. HeLa cells
were plated in 6-well plates (200,000 cells/well) and, on the following day, trans-
fected with either 2.5 µg of empty PX458 vector as a control or 2.5 µg of PX458
vector where guide oligonucleotides targeting C1QTNF1-AS1 were cloned together
with a symmetric single-stranded oligonucleotide donor86 (ssODN; IDT Inc., 4 µl
from 10 µM stock) containing the pAS flanked by homology arms (75 bp) to the
target site. Lipofectamine 3000 reagent (Thermo Fisher Scientific, L3000015) was
used as transfection reagent according to the manufacturer’s instructions. The
sequence of the symmetric ssODNs is as follows (5′ to 3′):
75 bp homology left arm-aataaaagatctttattttcattagatctgtgtgttggttttttgtgtg-75 bp
homology right arm
CTCACTGCGGGGCTCGGGAAGGAGGAAAGGAGTGAGCATGTCCTGCTCC
TGCATGTCCCTGCTTAAGCTCAGGACaataaaagatctttattttcattagatctgtgtgttggtttt
ttgtgtgCCCTTCCAGGCCAAGGACCCCAGCATAGACCCCAGGACAGGGCCCCA
AGGATCCCTGGCTCATGAGAGCGGCTTGC
The exon 1 of C1QTNF1-AS1 is shown in upper case. The pAS site is in bold
and contains BglII restriction sites (AGATCT) that were used for identification of
the positive clones. The PAM site (TGG) was abrogated to avoid further cleavage
by Cas9.
After 48 h, the GFP-positive cells were sorted using BD FACSAria Ilu (CRUK
Flow Cytometry Core Facility) and plated on 96-well plates with DMEM
supplemented with 20% FBS. Single-cell clones were expanded and genomic DNA
was extracted using Direct PCR Lysis reagent (Viagen, 201-Y; 25 µl/well) with
Proteinase K (Thermo Fisher Scientific, 25530-049; 0.4 mg/ml). The plates were
incubated for 1 h at 55 °C, followed by 45 min incubation at 85 °C. Two µl of
genomic DNA was used for screening by PCR amplification (Phusion® High-
Fidelity PCR Master Mix with HF Buffer, NEB, M0531S) of the targeted genomic
region. PCR conditions for C1QTNF1-AS1-guide 70 were: 98 °C 30 s, 98 °C 30 s,
70 °C 30 s, 72 °C 30 s (repeat 30×), 72 °C 90 s, 4 °C forever. After PCR, 5 µl was used
for BglII digestion (NEB, 2 h at 37 °C) and the products were loaded on a 2%
agarose gel to confirm the pAS insertion (Supplementary Fig. 8a). The rest of PCR
reaction (15 µl) was also loaded on the gel as a control. Uncropped scan of the gel is
provided in the Source Data file. The same genomic PCR product was also ligated
into pJET1.2/Blunt and transformed into bacteria (CloneJET; Thermo Fisher
Scientific, K1231). To ensure representation by both alleles, plasmids were isolated
and sequenced from a minimum of 5–10 bacterial colonies. This method revealed
that C1QTNF1-AS1 pAS clones were homozygously targeted clones. Four clones
were analysed (clone 95, 136, 153 and 169) by qPCR and live-cell imaging for the
mitotic phenotype, along with the wild-type controls (clone 2 and clone 5) that
were transfected with an empty vector PX458. We also attempted to perform pAS
insertion into exon 1 of linc00899 using two different sgRNAs. However, we failed
to obtain homozygous targeted clones, most likely due to the presence of four
copies of linc00899 in HeLa cells (https://cansar.icr.ac.uk/cansar/cell-lines/HELA/
copy_number_variation/). The list of PCR primers for CRISPR pAS insertion is
provided in Supplementary Table 8.
Mapping of 5′ and 3′ ends of linc00899 and C1QTNF1-AS1 by RACE. HeLa total
RNA (1 µg) was extracted and 5′ and 3′ RACE was performed using the Smarter
RACE Kit (Clontech, 634858). cDNA was synthesised using 5′ and 3′ RACE CDS
primers and SMARTer IIA oligo for template switching for 5′ RACE. cDNA ends
were then amplified by touchdown PCR. The first PCR (touchdown) used the
following conditions: 5 cycles of 94 °C/30 s, 72 °C/3 min; 5 cycles of 94 °C/30 s,
70 °C/30 s, 72 °C 3 min; 25 cycles of 94 °C/30 s, 68 °C/30 s, 72 °C/3 min. For nested
PCR, 2 µl of PCR reaction was diluted in 98 µl Tricine-EDTA buffer and used as a
template for the second PCR reaction with the following conditions: 25 cycles of
94 °C/30 s, 68 °C/30 s, 72 °C/3 min.
For linc00899, the first PCR used Universal Primer A mixed with linc00899-5R
outer 1=GATTACGCCAAGCTTacatcccggttcccacgaaaagcaacc for the 5′ ends or
linc00899-3Routerinner3=GATTACGCCAAGCTTccagggaggggaaaggagtcggcaat
for the 3′ ends. The second (nested) PCR used Nested Universal Primer A and
linc00899-5Routerinner1=GATTACGCCAAGCTTggagcaggcgaagagggagtgagggg
for the 5′ ends or linc00899-3R outerinner1=GATTACGCCAAGCTTggtcacagc
ctagccaagcccagcca for the 3′ ends.
For C1QTNF1-AS1, the first PCR used Universal Primer A mixed with
C1QTNF1-AS1-5-RACE-outer-1=GATTACGCCAAGCTTccaggcccctaatgatg
tcctttga for the 5′ ends or C1QTNF1-AS1-3RACE-outer-1=GATTACGCCAAGC
TTggaggaaaggagtgagcatgtcctg for the 3′ ends. The second nested PCR used Nested
Universal Primer A and C1QTNF1-AS1-5RACE-inner-2=GATTACGCCAAGCT
TGTCCTGATCTCCACCTGTCCCAAGC for the 5′ ends or C1QTNF1-AS1-
3RACE-inner-2=GATTACGCCAAGCTTGGAAACTTGGCAGACAGATCC
AGCC for the 3′ ends.
For linc00899, nine different 5′ sites and four different 3′ sites were identified.
For C1QTNF1-AS1, six different 5′ sites and four different 3′ sites were identified.
The fragments were purified after agarose gel electrophoresis with the QiaQuick
Gel Extraction Kit (QIAGEN), cloned in pRACE vector as per the kit instructions
and transformed into Stellar component cells (Clontech, 636763). The inserts were
verified by Sanger sequencing. Uncropped images of RACE results are presented in
the Source Data file.
RACE results for linc00899. The most common starting site for linc00899 was
CACGTCC, 87 bp upstream from the linc00899 TSS. The most common termi-
nation site for linc00899 was acagcaag. Capital italic letters indicate the region
upstream of linc00899 TSS (cggccgcccc) based on UCSC.
TGGCCTCGGAGGGTCAACACCTGAGGGCCCGAGGGGCATCCATGCCC
CCTCCTCCTTCCCTCCAGCCAAAGGTGGGGGGCAAAGCGCAGGGAAGAA
AACACCAGGAGAAAACCAGAGAGCTCTCGGTTCTCTTTTAAGAGCCCTGAT
GGCCGCAGCGCAGAGCCCGAGGGGAGGGAAAATGTCGGGAAAGATTCTCTT
CCGAACTTTGCGAGTCTTTGTTTGGGAGGCTGGGGGCTGACTTCGCCGGG
GGCCGGGCCGCGGGCTCGGCCGTGCGCTCCGGTGCAGCGGCCGAGGAGCC
CCGGCGCCCGCCACCCCGGGACACGCCCTCGCAGTCGAGCCCGGACCCCGA
CCCGGACCCCAGCGCCGCCGGGCGAGGGCGGGAGGGGGAGCGCTTACCAG
ATCGTCCCGAGCGCGCCGCGGTCCAGGCGGGCACAGCGCAGGGTCAAGTT
CACGTCCGGCCCGCGGGCTGCCCGAGGTCCCCGGGCGCGGCTGGGGCAGC
GGGAGGCGCGGGAGGCCGAGGTCCGGGTGGCCGCCGcggccgcccccgaagcgctg
ctgtcaccccggccgcgccccccaactttctgcacagtcgcggagctggaagtttccgggcttcgcggacacgctgggct
gggtttcagtcgcggctccgaggttggcaacaaagagggaaagaaggaggaaaagcaggccggggaggggaggaa
gagaaccgcgcggaggccgcggcgccgagagccccagaacttccaattctacccagaagcttttttcgtcgtgttttt
ctcttagacatgatcctctctgaggttggtcctgggcttccatacgtgattcatggaagaggtctcagccccaagagcccct
gagggtactgtccactccccctggaaacttccagaacctgacgtggggctgaagacatagaggctctgagagttacata
attgattctgactttggctgttggtcaacagtgtcataaggtaaaataaggctgttgtagaatctgctcagccagggagggg
aaaggagtcggcaatcaggtctcctcctgggcacctttgtgaggccagctggcgagagtggggggtgacactgaggtcc
cagcagctccaaatgcaggcagagccctgtcctcagagaaggtcacagcctagccaagcccagccaggtggatgggcc
cacggaacgcacaggaacctggaacggaggttgaaagcaggaagcacagtctgtgactccccagcccactctgcattc
gaccacttggggcccagaagcttcaggaaaggtgcacaaggtcactgggtcccagtactcccaacaggaaggtctggtc
cagggacagggctcttcccgactccccttagccacacgcaccagaagttctgcagtgcccagtgggcatagcagtccc
caagaatgacccagcactgaagctgagccaaagaacttggggagcgagccacaccccctcactccctcttcgcctgctc
cagacttgccaggcggttgcttttcgtgggaaccgggatgtcctcaccaccctgtccagggcccagccccatgtccc
tggcctgctacagctggaaaaaaaaaagagagatgtttgtttttatttgtttataaaaagaaaagtgttatatatataaca
tattatacctcatgaatacatacaattatttgtcaattaacaataaagaaaaatacagcaagcaaaaaagactctcttcca
caaaaatagtgttcattacagaaaagtacaaaaaaaaaaaaaaaaaactaagaggatatttagaattaagaaaaaac
taagagggtatttagaattaaaaaataaaaagaaaacaattacccatgaggtaattactgaatgcatttggttgaaa
gtccttctgctatattttccaaactgtatgtgtatatatgtgcgcatgcatatatgtgtttgtgtgtgtgtacacatatctata
tgaatggaccatatcgtaagttataaatgcatacatatattcatgtatatataatcattagatcatactataggttattttaca
gtctttttgttgaatacgttgtgagcattttatgtcattattttctacaagatttgaaaaataaagtataaataccagttaa.
Based on our sequencing results, linc00899 transcript varied from 1144 to 1532
bp in HeLa cells. We sequenced at least 10 clones per 5′ and 3′ RACE.
RACE results for C1QTNF1-AS1. The most common 5′ site was AGAGAACTA,
54 bp from the C1QTNF1-AS1 TSS. The most common 3′ site was tctggaa. Capital
italic letters indicate the region upstream of C1QTNF1-AS1 TSS (gaaggagg) based
on UCSC.
ATCACCCCAGCACAAGTGTCACACAGCCGTGACCTTGACAAGGACCCAG
AGATAAAGATCCTTCCCACATGGCTCCGAAGCCCCTCCCTTCCTGCTCACAC
CGCATGCCTCTCCCAGAGAACTAGAGGCTGCAGCGGCAGCAGTTGGAGCA
TCTCACTGCGGGGCTCGGgaaggaggaaaggagtgagcatgtcctgctcctgcatgtccctgcttaagct
caggactggcccttccaggccaaggaccccagcatagaccccaggacagggccccaaggatccctggctcatgaga
gcggcttgctgggctgccccaagagagcctgaaggaaacacattgttgagctgagctgacgtcgctgtttcttccagac
tgctctctaaagtgggcagggtagcgaccggccggctccgatggtgacgtcccactgccaaggggtgggagtgggga
gagtctccacagagcttcggagaagctgctaagATGGAAAAGTGGAAACTTGGCAGACA
GATCCAGCCTCCCTGGCCACTGGCCCATGCTCGTGGCTCCTGGATG
GCGCTGCCACGTTCTGAGCAGCTTGGGACAGGTGGAGATCAGGACTGG
CAGCTGCAAGGACACACCAGAGCCACAGAAACTAAAGAGAATTTCCA
AAAGGAGTCTATGGTGAAGTCTCTGAGGATGCAAAGAAGACAAGGA
GAATGAaaatccaatgaaagcctgattgtatttgttgaccttaaggaaagtgattttatggtacagcctctctg
gaagggagggtgtgttcgctcacagaatgcaaataccctttgaccccctaatctttcttctaggagtttctcctacaga
taaacttagaagggtgctcaaataagtaagttcaaggatatcctctgaagcattgccgtagtataaaaaaagcacaga
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taccctcaaaggacatcattaggggcctggtaaaataaattccacacagtggaacaccgtgtagctctttagagaataaa
cagctctctatatgtgatctggaaCAATCTCC.
Based on our sequencing results, C1QTNF1-AS1 transcript varied from 864 to
952 bp in HeLa cells. We sequenced at least 10 clones per 5′ and 3′ RACE.
Lentiviral overexpression of lncRNAs. To produce lentivirus, HEK293T cells
were first transfected with 15 µg of DNA, composed of 9 µg of the lentiviral vector
DNA containing the transgene, 4 µg of psPAX.2 and 2 µg of pMD2.G in the final
transfection volume of 1.5 ml (including 45 µl of Trans-Lt1 transfection reagent,
Mirus) using OptiMEM medium (Thermo Fisher Scientific). Viral supernatant was
collected 48 and 72 h post-transfection, spun down at 1800 × g for 5 min at +4 °C
and filtered through a 45-µm filter. For overexpression of linc00899 in HeLa and
RPE1 cells, linc00899 sequence (Labomics) and negative control vector (scrambled
linc00899 sequence) were cloned into pLenti6.3/TO/V5-DEST vector (also known
as lincXpress; kindly provided by John Rinn, University of Colorado) using the
Gateway cloning strategy70. To overexpress linc00899 from its endogenous locus
using CRISPRa, we used pHAGE EF1alpha dCAS9-VP64-HA (Addgene, #50918).
Two gRNA sequences targeting different regions of linc00899 (guides 1 and 2) were
cloned into pU6-sgRNA EF1Alpha-puro-T2A-BFP (Addgene, #60955). All clones
were verified by Sanger sequencing using mU6 forward primers (the mU6 sequence
is provided in Supplementary Table 8). HeLa and RPE1 cells were transduced with
lentivirus containing dCAS9-VP64 and two gRNA targeting linc00899 or with
lentivirus contacting negative gRNA (NC2) in the presence of polybrene (5 µg/ml,
Sigma). Twenty-four hours after viral transduction, the medium was exchanged
and RNA was collected 48 h later for qPCR analysis. The list of CRISPRa guide
sequences and primers to overexpress linc00899 from the lincXpress vector are
provided in Supplementary Tables 9 and 10, respectively.
Immunofluorescence. HeLa cells were seeded on coverslips in 6-well plates
(120,000/well), transfected the next day with siRNA or LNA gapmers and fixed 48
h post-transfection in ice-cold methanol (Acros Organics, 167830025) for 10 min
at −20 °C. The cells were then washed once in 1× PBS and permeabilised with PBS/
0.5%Triton-X100 (Acros Organics, 327371000)/0.5%Tween-20 (Promega, H5151)
for 5 min at RT followed by blocking in 5% BSA/PBS/0.001% Sodium Azide for
30 min at RT. Cells were incubated with primary antibodies overnight at 4 °C.
Antibodies against acetylated α-tubulin (Sigma, T6793, dilution 1:500) and α-
tubulin (Serotec, MCA78G, dilution 1:500) or against EB1 (CRUK, dilution 1:300,
ref. 87) and α-tubulin (Serotec, MCA78G, dilution 1:500) were used. Cells were
washed 3× for 10 min with PBS/0.1%Tween-20 and then incubated with secondary
antibodies (Supplementary Table 4) diluted in blocking-buffer for 1 h at RT.
After washing again 3× for 10 min with PBS/0.1%Tween-20, cells were stained with
1 µg/ml Hoechst (B2261, Sigma, diluted in PBS) for 10 min at RT. Coverslips were
mounted onto glass slides using Prolong Diamond Antifade Mountant (Thermo
Fischer Scientific, P36961). To determine the mitotic index, cells were stained with
antibodies against PHH3 (Millipore, 06-570, dilution 1:2000) and α-tubulin
(Sigma, TUB9026, dilution 1:1000). The mitotic index was calculated by counting
the cells in mitosis (positive for PHH3 and α-tubulin) and total number of cells
(Hoechst positive). For each sample, at least 100 cells were randomly counted by
fluorescence microscopy, and mitotic cells were scored from prophase to anaphase/
telophase.
For kinetochore analysis, HeLa cells were grown on coverslips, treated with the
indicated siRNAs or LNAs and fixed in PTEMF buffer (0.2% Triton X-100, 0.02 M
PIPES (pH 6.8), 0.01 M EGTA, 1 mM MgCl2, 4% formaldehyde) for 10 min at RT.
The cells were then washed twice in 1× PBS (5 min), permeabilised in 0.2% Triton
X-100 in PBS for 5 min at RT, washed twice in 1× PBS (5 min) and blocked as
above. Cells were then incubated with primary antibodies (α-tubulin, Sigma,
TUB9026, dilution 1:1000; CREST, Antibodies Inc., 15-234-0001, dilution 1:1000;
Mad2, Babco, 924601, dilution 1:100) overnight at 4 °C. CREST/Mad2 images were
acquired with 0.3 µm z-slices while 0.5 µm z-slices were used for acetyl α-tubulin/α-
tubulin images. The list of all primary and secondary antibodies is provided in
Supplementary Table 4.
Image processing and quantification. Imaging of fixed cells was performed on a
Leica Sp8 confocal microscope using a 100 ×1.4 numerical aperture Leica oil
objective. Images were taken at identical exposure times within each experiment
and were imported into ImageJ and Photoshop (CS6, Adobe). Images shown here
represent three-dimensional maximum intensity projections. To analyse the ratio
of α-tubulin to acetylated α-tubulin, raw integrated intensities were measured
(ImageJ) over the total z-stack plane using a circle selection around the mitotic
spindle (based on α-tubulin). The measured intensity values were divided by
the area of the selection and the background signal was subtracted. Afterwards,
the mean of the signal intensity over all z-stacks was calculated, and the ratio of the
signal of acetylated-tubulin to α-tubulin was determined. The total EB1 levels were
quantified as described above. Inter-KT distance was measured between single
kinetochore pairs visible in the same z-stack plane using ImageJ. We calculated the
distance between at least seven kinetochore pairs/cell from the single focal plane
using the manual line measurement tool.
Subcellular fractionation. The cells from a 150-mm dish were used to isolate RNA
from cytoplasmic, nucleoplasmic and chromatin fractions by TRIzol extraction70.
Turbo DNA-free Kit (Thermo Fischer Scientific, AM1907) was used to remove any
traces of DNA. Expression of target genes in each fraction was analysed by qPCR.
Data were normalised to the geometric mean of GAPDH and ACTB levels in each
cellular compartment. U1 small nuclear RNA was used as a positive control for
chromatin fraction.
Coding potential assessment for lncRNAs. The Coding-Potential Calculator88
(CPC; http://cpc.cbi.pku.edu.cn) and Coding Potential Assessment Tool89 (CPAT;
http://lilab.research.bcm.edu/cpat/index.php) were used to determine noncoding
potential. LncRNAs with CPC scores >1 and CPAT scores >0.364 were predicted to
have protein-coding capacity. The PhyloCSF90 score was taken from UCSC
(https://github.com/mlin/PhyloCSF/wiki).
Statistical analysis. The statistical significance of data was determined by two-
tailed Student’s t test in all experiments using GraphPad Prism unless indicated
otherwise. P values >0.05 were considered statistically not significant.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
A reporting summary for this article is available as a Supplementary Information file.
Sequencing data are available in the ArrayExpress database (http://www.ebi.ac.uk/
arrayexpress) with the accession codes E-MTAB-7432 (RNA-seq), E-MTAB-7418
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8a–c; and 9b and Supplementary Figs. 2a–d; 3a, b; 4a, b; 5a, b; 6a, c, e, f; 7a, d; 8a, c, d;
9a–c; 10a–e; and 14a, b are provided as a Source Data file. All data are available from the
corresponding authors upon reasonable request.
Code availability
All code used in this analysis is available at https://github.com/MarioniLab/
LncScreen2018.
Received: 28 May 2019; Accepted: 9 February 2020;
References
1. Iyer, M. K. et al. The landscape of long noncoding RNAs in the human
transcriptome. Nat. Genet. 47, 199–208 (2015).
2. Hon, C. C. et al. An atlas of human long non-coding RNAs with accurate 5’
ends. Nature 543, 199–204 (2017).
3. Fatica, A. & Bozzoni, I. Long non-coding RNAs: new players in cell
differentiation and development. Nat. Rev. Genet. 15, 7–21 (2014).
4. Kitagawa, M., Kitagawa, K., Kotake, Y., Niida, H. & Ohhata, T. Cell cycle
regulation by long non-coding RNAs. Cell. Mol. Life Sci. 70, 4785–4794
(2013).
5. Quinn, J. J. & Chang, H. Y. Unique features of long non-coding RNA
biogenesis and function. Nat. Rev. Genet. 17, 47–62 (2016).
6. Huarte, M. The emerging role of lncRNAs in cancer. Nat. Med. 21, 1253–1261
(2015).
7. Wapinski, O. & Chang, H. Y. Long noncoding RNAs and human disease.
Trends Cell Biol. 21, 354–361 (2011).
8. Huarte, M. et al. A large intergenic noncoding RNA induced by p53 mediates
global gene repression in the p53 response. Cell 142, 409–419 (2010).
9. Liu, X., Li, D., Zhang, W., Guo, M. & Zhan, Q. Long non-coding RNA gadd7
interacts with TDP-43 and regulates Cdk6 mRNA decay. EMBO J. 31,
4415–4427 (2012).
10. Kim, J. et al. LncRNA OIP5-AS1/cyrano suppresses GAK expression to
control mitosis. Oncotarget 8, 49409–49420 (2017).
11. Wang, Z. D. et al. Long noncoding RNA lnc-RI is a new regulator of mitosis
via targeting miRNA-210-3p to release PLK1 mRNA activity. Sci. Rep. 6,
25385 (2016).
12. Marchese, F. P. et al. A long noncoding RNA regulates sister chromatid
cohesion. Mol. Cell 63, 397–407 (2016).
13. Rosic, S., Kohler, F. & Erhardt, S. Repetitive centromeric satellite RNA is
essential for kinetochore formation and cell division. J. Cell Biol. 207, 335–349
(2014).
14. Lee, S. et al. Noncoding RNA NORAD regulates genomic stability by
sequestering PUMILIO proteins. Cell 164, 69–80 (2016).
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-14978-7 ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:1851 | https://doi.org/10.1038/s41467-020-14978-7 |www.nature.com/naturecommunications 19
15. Tichon, A., Perry, R. B., Stojic, L. & Ulitsky, I. SAM68 is required for
regulation of Pumilio by the NORAD long noncoding RNA. Genes Dev. 32,
70–78 (2018).
16. Marchese, F. P., Raimondi, I. & Huarte, M. The multidimensional
mechanisms of long noncoding RNA function. Genome Biol. 18, 206 (2017).
17. Kittler, R. et al. An endoribonuclease-prepared siRNA screen in human cells
identifies genes essential for cell division. Nature 432, 1036–1040 (2004).
18. Neumann, B. et al. Phenotypic profiling of the human genome by time-lapse
microscopy reveals cell division genes. Nature 464, 721–727 (2010).
19. Kittler, R. et al. Genome-scale RNAi profiling of cell division in human tissue
culture cells. Nat. Cell Biol. 9, 1401–1412 (2007).
20. Schmitz, M. H. et al. Live-cell imaging RNAi screen identifies PP2A-B55alpha
and importin-beta1 as key mitotic exit regulators in human cells. Nat. Cell
Biol. 12, 886–893 (2010).
21. Liu, S. J. et al. CRISPRi-based genome-scale identification of functional long
noncoding RNA loci in human cells. Science 355, eaah7111 (2017).
22. Liu, Y. et al. Genome-wide screening for functional long noncoding RNAs in
human cells by Cas9 targeting of splice sites. Nat. Biotechnol. 36, 1203–1210
(2018).
23. Notzold, L. et al. The long non-coding RNA LINC00152 is essential for cell
cycle progression through mitosis in HeLa cells. Sci. Rep. 7, 2265 (2017).
24. Gergely, F., Draviam, V. M. & Raff, J. W. The ch-TOG/XMAP215 protein is
essential for spindle pole organization in human somatic cells. Genes Dev. 17,
336–341 (2003).
25. Stojic, L. et al. Specificity of RNAi, LNA and CRISPRi as loss-of-function
methods in transcriptional analysis. Nucleic Acids Res. 46, 5950–5966 (2018).
26. Su, K. C., Takaki, T. & Petronczki, M. Targeting of the RhoGEF Ect2 to the
equatorial membrane controls cleavage furrow formation during cytokinesis.
Dev. Cell 21, 1104–1115 (2011).
27. Hezroni, H. et al. Principles of long noncoding RNA evolution derived from
direct comparison of transcriptomes in 17 species. Cell Rep. 11, 1110–1122
(2015).
28. Ulitsky, I. Evolution to the rescue: using comparative genomics to understand
long non-coding RNAs. Nat. Rev. Genet. 17, 601–614 (2016).
29. Marin-Bejar, O. et al. The human lncRNA LINC-PINT inhibits tumor cell
invasion through a highly conserved sequence element. Genome Biol. 18, 202
(2017).
30. Quinn, J. J. et al. Revealing long noncoding RNA architecture and functions
using domain-specific chromatin isolation by RNA purification. Nat.
Biotechnol. 32, 933–940 (2014).
31. Consortium, G. T. The Genotype-Tissue Expression (GTEx) project. Nat.
Genet. 45, 580–585 (2013).
32. Wheeler, T. M. et al. Targeting nuclear RNA for in vivo correction of
myotonic dystrophy. Nature 488, 111–115 (2012).
33. Lennox, K. A. & Behlke, M. A. Cellular localization of long non-coding RNAs
affects silencing by RNAi more than by antisense oligonucleotides. Nucleic
Acids Res. 44, 863–877 (2016).
34. Levitt, N., Briggs, D., Gil, A. & Proudfoot, N. J. Definition of an efficient
synthetic poly(A) site. Genes Dev. 3, 1019–1025 (1989).
35. Tirian, L. et al. TPPP/p25 promotes tubulin assemblies and blocks mitotic
spindle formation. Proc. Natl Acad. Sci. USA 100, 13976–13981 (2003).
36. Tokesi, N. et al. TPPP/p25 promotes tubulin acetylation by inhibiting histone
deacetylase 6. J. Biol. Chem. 285, 17896–17906 (2010).
37. DeBonis, S., Neumann, E. & Skoufias, D. A. Self protein-protein interactions
are involved in TPPP/p25 mediated microtubule bundling. Sci. Rep. 5, 13242
(2015).
38. Otzen, D. E. et al. p25alpha is flexible but natively folded and binds tubulin
with oligomeric stoichiometry. Protein Sci. 14, 1396–1409 (2005).
39. Webster, D. R. & Borisy, G. G. Microtubules are acetylated in domains that
turn over slowly. J. Cell Sci. 92(Pt. 1), 57–65 (1989).
40. Jordan, M. A. et al. Mitotic block induced in HeLa cells by low concentrations
of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death.
Cancer Res. 56, 816–825 (1996).
41. Derry, W. B., Wilson, L. & Jordan, M. A. Substoichiometric binding of taxol
suppresses microtubule dynamics. Biochemistry 34, 2203–2211 (1995).
42. Jordan, M. A., Toso, R. J., Thrower, D. & Wilson, L. Mechanism of mitotic
block and inhibition of cell proliferation by taxol at low concentrations. Proc.
Natl Acad. Sci. USA 90, 9552–9556 (1993).
43. Akhmanova, A. & Steinmetz, M. O. Control of microtubule organization and
dynamics: two ends in the limelight. Nat. Rev. Mol. Cell Biol. 16, 711–726
(2015).
44. Musacchio, A. & Salmon, E. D. The spindle-assembly checkpoint in space and
time. Nat. Rev. Mol. Cell Biol. 8, 379–393 (2007).
45. Chen, R. H., Waters, J. C., Salmon, E. D. & Murray, A. W. Association of
spindle assembly checkpoint component XMAD2 with unattached
kinetochores. Science 274, 242–246 (1996).
46. Li, Y. & Benezra, R. Identification of a human mitotic checkpoint gene:
hsMAD2. Science 274, 246–248 (1996).
47. Barr, A. R. & Gergely, F. MCAK-independent functions of ch-Tog/XMAP215
in microtubule plus-end dynamics. Mol. Cell. Biol. 28, 7199–7211 (2008).
48. Acevedo, K. et al. The phosphorylation of p25/TPPP by LIM kinase 1 inhibits
its ability to assemble microtubules. Exp. Cell Res. 313, 4091–4106 (2007).
49. Goff, L. A. & Rinn, J. L. Linking RNA biology to lncRNAs. Genome Res. 25,
1456–1465 (2015).
50. Gilbert, L. A. et al. Genome-scale CRISPR-mediated control of gene repression
and activation. Cell 159, 647–661 (2014).
51. Skene, P. J., Henikoff, J. G. & Henikoff, S. Targeted in situ genome-wide
profiling with high efficiency for low cell numbers. Nat. Protoc. 13, 1006–1019
(2018).
52. Simon, M. D. et al. The genomic binding sites of a noncoding RNA. Proc. Natl
Acad. Sci. USA 108, 20497–20502 (2011).
53. Simon, M. D. et al. High-resolution Xist binding maps reveal two-step
spreading during X-chromosome inactivation. Nature 504, 465–469 (2013).
54. Vance, K. W. et al. The long non-coding RNA Paupar regulates the expression
of both local and distal genes. EMBO J. 33, 296–311 (2014).
55. West, J. A. et al. The long noncoding RNAs NEAT1 and MALAT1 bind active
chromatin sites. Mol. Cell 55, 791–802 (2014).
56. Vance, K. W. Mapping long noncoding RNA chromatin occupancy using
capture hybridization analysis of RNA targets (CHART). Methods Mol. Biol.
1468, 39–50 (2017).
57. Engreitz, J. M., Ollikainen, N. & Guttman, M. Long non-coding RNAs: spatial
amplifiers that control nuclear structure and gene expression. Nat. Rev. Mol.
Cell Biol. 17, 756–770 (2016).
58. Hacisuleyman, E. et al. Topological organization of multichromosomal
regions by the long intergenic noncoding RNA Firre. Nat. Struct. Mol. Biol. 21,
198–206 (2014).
59. Maass, P. G. et al. A misplaced lncRNA causes brachydactyly in humans. J.
Clin. Invest. 122, 3990–4002 (2012).
60. Heng, Y. W. et al. TPPP acts downstream of RhoA-ROCK-LIMK2 to regulate
astral microtubule organization and spindle orientation. J. Cell Sci. 125,
1579–1590 (2012).
61. Lehotzky, A. et al. Tubulin polymerization-promoting protein (TPPP/p25) is
critical for oligodendrocyte differentiation. Glia 58, 157–168 (2010).
62. Hlavanda, E. et al. Phosphorylation blocks the activity of tubulin
polymerization-promoting protein (TPPP): identification of sites targeted by
different kinases. J. Biol. Chem. 282, 29531–29539 (2007).
63. Atianand, M. K. et al. A long noncoding RNA lincRNA-EPS acts as a
transcriptional brake to restrain inflammation. Cell 165, 1672–1685 (2016).
64. Ntini, E. et al. Long ncRNA A-ROD activates its target gene DKK1 at its
release from chromatin. Nat. Commun. 9, 1636 (2018).
65. Fu, M. M. et al. The Golgi outpost protein TPPP nucleates microtubules and is
critical for myelination. Cell 179, 132.e14–146.e14 (2019).
66. Mino, R. E. et al. Drosophila Ringmaker regulates microtubule stabilization
and axonal extension during embryonic development. J. Cell Sci. 129,
3282–3294 (2016).
67. Dickinson, M. E. et al. High-throughput discovery of novel developmental
phenotypes. Nature 537, 508–514 (2016).
68. Olah, J. et al. Interactions of pathological hallmark proteins: tubulin
polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein. J.
Biol. Chem. 286, 34088–34100 (2011).
69. Olah, J. & Ovadi, J. Dual life of TPPP/p25 evolved in physiological and
pathological conditions. Biochem. Soc. Trans. 42, 1762–1767 (2014).
70. Stojic, L. et al. Transcriptional silencing of long noncoding RNA GNG12-AS1
uncouples its transcriptional and product-related functions. Nat. Commun. 7,
10406 (2016).
71. Barr, A. R., Kilmartin, J. V. & Gergely, F. CDK5RAP2 functions in centrosome
to spindle pole attachment and DNA damage response. J. Cell Biol. 189, 23–39
(2010).
72. Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose
program for assigning sequence reads to genomic features. Bioinformatics 30,
923–930 (2014).
73. Ritchie, M. E. et al. limma powers differential expression analyses for RNA-
sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
74. Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. voom: Precision weights unlock
linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29
(2014).
75. Phipson, B., Lee, S., Majewski, I. J., Alexander, W. S. & Smyth, G. K. Robust
hyperparameter estimation protects against hypervariable genes and improves
power to detect differential expression. Ann. Appl. Stat. 10, 946–963 (2016).
76. McCarthy, D. J. & Smyth, G. K. Testing significance relative to a fold-change
threshold is a TREAT. Bioinformatics 25, 765–771 (2009).
77. Berger, R. L. & Hsu, J. C. Bioequivalence trials, intersection-union tests and
equivalence confidence sets. Stat. Sci. 11, 283–302 (1996).
78. Ernst, C., Eling, N., Martinez-Jimenez, C. P., Marioni, J. C. & Odom, D. T.
Staged developmental mapping and X chromosome transcriptional dynamics
during mouse spermatogenesis. Nat. Commun. 10, 1251 (2019).
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-14978-7
20 NATURE COMMUNICATIONS |         (2020) 11:1851 | https://doi.org/10.1038/s41467-020-14978-7 | www.nature.com/naturecommunications
79. Liao, Y., Smyth, G. K. & Shi, W. The Subread aligner: fast, accurate and
scalable read mapping by seed-and-vote. Nucleic Acids Res. 41, e108 (2013).
80. Lun, A. T. & Smyth, G. K. From reads to regions: a Bioconductor workflow to
detect differential binding in ChIP-seq data. F1000Res 4, 1080 (2015).
81. Robinson, M. D. & Oshlack, A. A scaling normalization method for
differential expression analysis of RNA-seq data. Genome Biol. 11, R25
(2010).
82. Lun, A. T., Chen, Y. & Smyth, G. K. It’s DE-licious: a recipe for differential
expression analyses of RNA-seq experiments using quasi-likelihood methods
in edgeR. Methods Mol. Biol. 1418, 391–416 (2016).
83. Lun, A. T. & Smyth, G. K. De novo detection of differentially bound regions
for ChIP-seq data using peaks and windows: controlling error rates correctly.
Nucleic Acids Res. 42, e95 (2014).
84. Hahne, F. & Ivanek, R. Visualizing genomic data using Gviz and
Bioconductor. Methods Mol. Biol. 1418, 335–351 (2016).
85. Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat.
Protoc. 8, 2281–2308 (2013).
86. Richardson, C. D., Ray, G. J., DeWitt, M. A., Curie, G. L. & Corn, J. E.
Enhancing homology-directed genome editing by catalytically active and
inactive CRISPR-Cas9 using asymmetric donor DNA. Nat. Biotechnol. 34,
339–344 (2016).
87. Zyss, D., Ebrahimi, H. & Gergely, F. Casein kinase I delta controls centrosome
positioning during T cell activation. J. Cell Biol. 195, 781–797 (2011).
88. Kong, L. et al. CPC: assess the protein-coding potential of transcripts using
sequence features and support vector machine. Nucleic Acids Res. 35,
W345–W349 (2007).
89. Wang, L. et al. CPAT: Coding-Potential Assessment Tool using an alignment-
free logistic regression model. Nucleic Acids Res. 41, e74 (2013).
90. Lin, M. F., Jungreis, I. & Kellis, M. PhyloCSF: a comparative genomics method
to distinguish protein coding and non-coding regions. Bioinformatics 27,
i275–i282 (2011).
Acknowledgements
We thank all the members of Gergely and Odom groups for helpful discussions and Julia
Tischer for critical reading of the manuscript. We also thank the Genomics, Microscopy,
FACS and Research Instrumentation and Cell Service Core Facilities at the CRUK
Cambridge Institute. We thank Keith Vance (University of Bath, UK) and Matthew
Simon (Yale, USA) for the help with the CHART-seq protocol, John Rinn (University of
Colorado) for the lincXpress vector, Steve Henikoff (Fred Hutchinson Cancer Research
Center, USA) for providing the reagents for CUT&RUN and Irene Cantone (University
Federico II of Naples) for assistance with the DNA FISH. This work was made possible
by funding from Cancer Research UK (C14303/A17197 to D.T.O., F.G., and J.C.M.,
A24455 to F.G., and A20412 to D.T.O.). We also acknowledge the support of the
University of Cambridge, the Wellcome Trust (WT202878; to D.T.O.), European
Research Council (615584; to D.T.O.), BBSRC Stratageic LoLa grant (BB/M00354X/1 to
C.B. and A.R.B.) and Hutchison Whampoa Limited.
Author contributions
Conception and design of study: L.S., F.G., and D.T.O. Data acquisition: L.S., A.T.L.L.,
P.M., C.E., A.M.R., J.M., A.R.B., and V.B. Data analyses and interpretation: L.S., A.T.L.L.,
P.M., A.R.B., J.C.M., C.B., D.T.O., and F.G. Writing the paper: L.S., A.T.L.L., D.T.O., and
F.G. with input from all of the authors wrote the manuscript.
Competing interests
The authors declare no competing interests.
Additional information
Supplementary information is available for this paper at https://doi.org/10.1038/s41467-
020-14978-7.
Correspondence and requests for materials should be addressed to L.S., D.T.O. or F.G.
Peer review information Nature Communications thanks the anonymous reviewers for
their contribution to the peer review of this work. Peer reviewer reports are available.
Reprints and permission information is available at http://www.nature.com/reprints
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons licence, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons licence, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons licence and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this licence, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2020
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-14978-7 ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:1851 | https://doi.org/10.1038/s41467-020-14978-7 |www.nature.com/naturecommunications 21
